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Abstract 
This report illustrates how to use two statistic methods to investigate the 
performance of a new technique to detect breast cancer and lung cancer at early stages. 
The two methods include logistic regression and classification and regression tree (CART).  
It is found that the technique is effective in detecting breast cancer and lung cancer, with 
both sensitivity and specificity close to 0.9. But the ability of this technique to predict the 
actual stages of cancer is low. The age variable improves the ability of logistic regression in 
predicting the existence of breast cancer for the samples used in this report. But since the 
sample sizes are small, it is impossible to conclude that including the age variable helps the 
prediction of breast cancer.  Including the age variable does not improve the ability to 
predict the existence of lung cancer. If the age variable is excluded, CART and logistic 
regression give a very close result.  
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Chapter 1 - Introduction to the project 
 1.1 Aim of the project 
Data for this project were obtained from an experiment conducted by Dr. Bossmann and his 
coworkers in the Chemistry Department at Kansas State University. This experiment is 
aimed at testing the ability of a newly-developed nanoparticle in detecting cancer at an 
early stage by measuring enzyme activity in individuals. A small amount of blood or urine is 
obtained and iron nanoparticles coated with amino acids and a dye are added. The amino 
acids and dye can react with enzymes in the patients. Different types of cancers or different 
stages of cancer could lead to different enzyme patterns. The enzyme pattern may then be 
used to identify cancer by doctors. This test can also be used to distinguish between 
cancers that commonly occur in the human body, and monitor cancer in the treatment 
process. The detection process is roughly 60 minutes, and is supposed to be reduced to 5 
minutes.  
The raw data for this project include patients’ cancer stage, age, and a number for enzyme 
activity. The aim of this project is to investigate methods for predicting stage of cancer for 
any patient based on his or her enzyme activity in the test.  
 1.2 Measurement procedure 
The measurement procedure is represented in Figure 1-1. For each test, there are two 
groups of individuals, a patient group and a control group. Iron nanoparticles covered with 
amino acid and a dye were added into urine or blood of all individuals. After 1 hour, 
enzyme patterns were measured three times from one sample. 
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Figure 1-1 Procedure to test enzyme activity in individuals 
 
 1.3 Overview of report 
In this report, three datasets related to the above diagnostic test are analyzed using two 
statistical methods, logistic regression and classification and regression tree (CART). The 
aim is to find a good method to predict the stage of cancer for a patient based on his or her 
enzyme activity. For each analysis, a measure of sensitivity and specificity for the test is 
estimated. These in turn are used to produce a receiver operation characteristic (ROC) 
 Fe nanoparticles covered with amino 
acid and dye
Fe
Fe
Fe
Fe
F
e
Blood or urine
Injected 
into
After 1 
hour
Enzyme patterns are detected three 
times from one sample
Data 1 Data 3
Data 2
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curve to determine an optimal cutoff to predict cancer or no cancer. Chapter 2 is a 
literature review on logistic regression and CART. Chapter 3 and Chapter 4 discuss how to 
use these methods to analyze the datasets collected for patients with breast cancer using a 
CathB nanoparticle and a MP nanoparticle, respectively, to induce enzyme activity. Then in 
Chapter 5, the same method is used to analyze the dataset collected for patients with lung 
cancer using a MP nanoparticle to induce enzyme activity. 
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Chapter 2 - Literature Review 
 2.1 Common measures for assessing diagnostic test 
Diagnostic tests are often used to diagnose or detect disease, for example, using a new 
instrument in identifying the presence of cancer. Sensitivity and specificity are the most 
commonly used statistical measures that evaluate the performance of a diagnostic test. (1) (2) 
Sensitivity is the proportion of true positives that are correctly identified by the test. 
Specificity is the proportion of true negatives that are correctly identified by the test. (1) 
True positive means the individual tested has a disease or a symptom. A perfect predictor 
for the binary classification test would lead to 100 % sensitivity and 100 % specificity. But 
in reality, sensitivity and specificity will always be less than 100 %. When a new test 
method is proposed, these two measures are always reported.  
Specificity =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕 𝑎𝑏𝑛𝑜𝑟𝑚𝑎𝑙 𝑝𝑎𝑡𝑕𝑜𝑙𝑜𝑔𝑦 𝑡𝑕𝑎𝑡 𝑎𝑟𝑒 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕 𝑎𝑏𝑛𝑜𝑟𝑚𝑎𝑙 𝑝𝑎𝑡𝑕𝑜𝑙𝑜𝑔𝑦
 
Sensitivity =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕𝑜𝑢𝑡 𝑎𝑏𝑛𝑜𝑟𝑚𝑎𝑙 𝑝𝑎𝑡𝑕𝑜𝑙𝑜𝑔𝑦 𝑡𝑕𝑎𝑡 𝑎𝑟𝑒 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕𝑜𝑢𝑡 𝑎𝑏𝑛𝑜𝑟𝑚𝑎𝑙 𝑝𝑎𝑡𝑕𝑜𝑙𝑜𝑔𝑦
 
 
Besides sensitivity and specificity, it is also necessary to know how good the test is at 
predicting an abnormality. The positive predictive value (PPV) and negative predictive 
value (NPV) are used for this purpose. (2) PPV is the proportion of patients with positive test 
results who are correctly diagnosed. NPV is the proportion of patients with negative test 
results who are correctly diagnosed. (2) A good test should have a high PPV and a high NPV. 
But PPV and NPV are functions of sensitivity, specificity and prevalence; even if the 
sensitivity and specificity are high, PPV will be much lower than 100 % when the 
prevalence of the disease is low. Formulas for PPV, NPV and prevalence are as follows. 
PPV =
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 + (1 − 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦) ∗ (1 − 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒)
 
NPV =
𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒
(1 − 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦) ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 + 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 ∗ (1 − 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒)
 
Prevalence of abnormality =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑏𝑛𝑜𝑟𝑚𝑎𝑙 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠 𝑖𝑛 𝑡𝑕𝑒 𝑡𝑒𝑠𝑡
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A likelihood ratio is another number which is used to assess the performance of a test. It is 
calculated by sensitivity/ (1-specificity). (3) A likelihood ratio is used to compare the 
probability of getting positive result if the patient truly had the condition of interest with 
the corresponding probability if the patient was healthy. A high likelihood ratio is desired 
and can show that the test is useful. (3)  
Likelihood ratio =
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
(1 − 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦)
 
 
 2.2 Introduction to statistical analysis methods used in this project 
 2.2.1 Introduction to the logistic regression model 
Regression models are an important part of data analysis which involves describing the 
relationship between a response and explanatory response variables. When the response 
has one or several possible values, logistic regression is a common method. The purpose of 
logistic regression is to find the best fitting and biologically reasonable model for the 
relationship between a response variable and explanatory variables. For a logistic 
regression, the random component is the condition of the response, either success or 
failure. (5) (6)  
Maximum likelihood is the method for estimation of parameters in a logistic regression 
model. This method gives estimates for the unknown parameters which maximize the 
probability of obtaining the observed set of data. (7) When the response is binary, either 
failure or success, a logistic model is fit to estimate the probability of success given a fixed 
value of an explanatory variable or fixed values of several explanatory variables, denoted as 
P(Y = 1|x). (7) The format of logistic regression equation is  
logit π(x) = α + β1x1 + 𝛽2x2 + ⋯ 
where π(x) is the probability of success, α is the intercept of the model, 𝛽𝑖 is the coefficient 
for the ith predictor. Rearrangement of this fitted model gives the estimated probability of 
success 
π(x)̂ =
𝑒α̂+β1̂x1+𝛽2̂x2+⋯
1 + 𝑒α̂+β1̂x1+𝛽2̂x2+⋯
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For each individual, the 95% confidence interval for a probability is computed using the 
following two steps, assuming one explanatory variable. 
Step 1 Make a confidence interval for logit(π(x)): (l, u) 
SE(?̂? + ?̂?x) = √𝑣𝑎𝑟 (?̂?) + 𝑥2𝑣𝑎𝑟(?̂?) + 2𝑐𝑜𝑣(?̂?, ?̂?) 
(?̂? + ?̂?x) ± 𝑍𝛼/2SE(?̂? + ?̂?x) 
Step 2 Make a confidence interval  
(
𝑒𝑙
1+𝑒𝑙
,
𝑒𝑢
1+𝑒𝑢
) for π(x) 
When the response variables have more than two categories, several logit models can be 
used. If there are J possible values for the response variable, a set of J-1 equations should be 
fit.  
𝜋1=probability that y is in category 1 
𝜋2=probability that y is in category 2 
𝜋𝐽=probability that y is in the last category and is used as the baseline 
The model is log
𝜋𝑗
𝜋𝐽
= 𝛼𝑗 + 𝛽𝑗𝑥, if only one x variable is in the model.                                
𝜋?̂? =
exp (𝛼?̂? + 𝛽?̂?𝑥)
∑ exp (𝛼ℎ̂ + 𝛽ℎ̂𝑥)
𝐽
ℎ=1
 
where the parameters for the last baseline category are 0, i.e., 𝛼𝐽 = 𝛽𝐽 = 0. 
 𝜋𝐽 = 1 − 𝜋1 − 𝜋2 ⋯ − 𝜋𝐽−1 
The goodness-of-fit assessment in a logistic regression model is by a statistic called 
deviance, denoted by D. (5) Deviance is used to test if the current model is appropriate. The 
expression for deviance is  
D = −2ln [
𝑙𝑖𝑘𝑒𝑙𝑖𝑕𝑜𝑜𝑑 𝑜𝑓 𝑡𝑕𝑒 𝑐𝑢𝑟𝑟𝑒𝑛𝑡 𝑚𝑜𝑑𝑒𝑙
𝑙𝑖𝑘𝑒𝑙𝑖𝑕𝑜𝑜𝑑 𝑜𝑓 𝑡𝑕𝑒 𝑠𝑎𝑡𝑢𝑟𝑎𝑡𝑒𝑑 𝑚𝑜𝑑𝑒𝑙
] 
In order to test the significance of the coefficients, one needs to compare the value of D with 
and without the variable in question. (5) 
G = D(for the model without the variable) − D(for the model with the variable) 
= −2ln [
𝑙𝑖𝑘𝑒𝑙𝑖𝑕𝑜𝑜𝑑 𝑤𝑖𝑡𝑕𝑜𝑢𝑡 𝑡𝑕𝑒 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒
𝑙𝑖𝑘𝑒𝑙𝑖𝑕𝑜𝑜𝑑 𝑤𝑖𝑡𝑕 𝑡𝑕𝑒 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒
] 
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The statistic G asymptotically follows a chi-square distribution with 1 degree of freedom 
under the hypothesis that the coefficient for the tested variable is 0. As a result, a chi-
square test can be used to approximately test the significance of coefficients for different 
explanatory variables. 
 
 2.2.2 ROC curves 
For quantitative tests, there must be a way to assess the accuracy of the test and there 
should be a decision threshold of probability in order to provide a prediction of 
success/false. The sensitivity and specificity of a test will be changed with the decision 
threshold accordingly.  
A receiver operating characteristic (ROC) curve can be used to assess the accuracy of the 
diagnostic test and to give a cut-off probability for the prediction of the response. (8) A ROC 
curve summarizes predictive power for all possible thresholds and is a plot of sensitivity as 
a function of (1-specificity) for the possible threshold or cut-off probability. It measures the 
ability of the test to correctly classify those with and without the disease. The curve 
commonly has a concave shape and connects the points (0,0) and (1,1). (9)  The area under 
the ROC curve is the same as the concordance index which is the value of a measure of 
predictive power. (10) The higher the area, the greater the predictive power of the test. If the 
concordance index is 0.5, the predictions were no better than random guessing. The 
accuracy of a diagnostic test is classified following a conventional guide: if the area is from 
0.9 to 1, the accuracy of the test is excellent; if the area is from 0.8 to 0.9, the accuracy of the 
test is good; if the area is from 0.7 to 0.8, the accuracy of the test is fair; if the area is 0.6 to 
0.7, the accuracy of the test is poor; if the area is from 0.5 to 0.6, the accuracy of the test 
fails. (10) But an ROC curve can only be used for a test with binary responses.  
There are three criteria to find an optimal threshold of probability from the ROC curve. (9) 
The first two methods give equal weight to sensitivity and specificity and consider no 
ethical or cost constraints. The third criterion considers financial cost for correct and false 
diagnoses, cost of discomfort to a person caused by treatment, and cost of further 
investigation. The third method is seldom used because of its complexity. In this literature 
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review, only the first two methods are discussed. Shown in Figure 2-1 is a ROC curve. The 
first method computes the distance from each point on the ROC curve to the point (0, 1). 
The point with the shortest distance is the optimal threshold. The second method computes 
the vertical distance from each point on the ROC curve to the line of equality and the point 
with the maximum vertical distance is the optimal threshold. The vertical distance is called 
the Youden index. 
Figure 2-1 Methods to find the best cut-off from the ROC curve 
 
 
 2.2.3 Introduction to classification and regression trees 
The method of classification and regression trees (CART) is used to select variables and 
their interactions which are important in determining an outcome. (11; 12) CART can also be 
used to classify statistical data. If the dependent variable is continuous, CART produces a 
regression tree. If the dependent variable is categorical, CART produces a classification tree. 
The purpose of CART is to find a set of classifiers which are responsible for a given 
phenomenon. Using these classifiers, it is possible that the outcome of a new observation 
can be predicted by these classifiers. The steps in the tree-building process involve (1) 
building a large tree with many nodes, (2) combining some of the branches to generate 
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different subtrees, and (3) choosing the best tree among all the subtrees.  The split of a 
CART node begins with a simple question requiring a yes/no answer, such as is the value of 
a variable, Xo, less than or greater than a particular value. Based on the answer, the sample 
is split into left and right subsamples. Then the subsamples are split further based on other 
questions until the subsamples are homogeneous or contain two few observations. (11; 12; 13) 
The variable that is chosen to divide the dataset into two groups, and its value, is 
determined by the longest reduction in deviance from the parent mode to the two children 
(subsample) nodes. With a continuous response variable, the deviance of a node is the 
sums of squared derivations about the mean of that node. In the case of binary data, the 
deviance is that used for binomial data. 
In this literature review, a dataset called Kyphosis is used to illustrate how the CART model 
is used to build a tree. This dataset involves observations on 81 children undergoing 
corrective surgery of the spine. In the dataset, there are three risk factors for kyphosis after 
the surgery, including age in months (called Age), the starting vertebral level of the surgery 
(called Start), and the number of vertebrae involved (called Number). A classification and 
regression tree is used to predict if a child has kyphosis after the surgery based on the 
levels of the three risk factors. The tree is shown in Figure 2-2. The tree is built starting 
with a question if the age of the child is greater or equal to 8.5 months. If the answer to the 
question is yes, this child is partitioned to the left subsamples. If the answer is no, the child 
is portioned to the right of the subsamples and predicted to have kyphosis. Splitting the 
original dataset based on whether the child was greater or less than 8.5 months obtained 
the greatest reduction in deviance versus all other possible splits. The split of the left 
subsamples is continued with the second question if the starting vertebral level of the 
surgery is greater or equal to 14.5. If the answer is yes, the child is predicted to not have 
kyphosis. If the answer is no, this child is partitioned to the right sub-subsamples. The sub-
subsamples are split further based on other questions with the goal of each split to improve 
the accuracy of predictions, i.e., to obtain homogenous nodes. There are two numbers 
under each node in Figure 2-2. The first number represents out of the total individuals in 
the subsample, how many of them do not have kyphosis. The second number represents 
how many of them have kyphosis. For example, in the right most node, which is labeled 
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present, 8 children did not develop kyphosis after the surgery, whereas, 11 children 
developed kyphosis after the surgery. 
 
The strengths of CART include (1) no assumption of the distributions for the variables is 
needed, (2) the explanatory variables can be either continuous, or categorical, or a 
combination of both, (3) outliers do not affect the result as much as other modeling 
techniques, (4) transformation of explanatory variables does not have an effect on the tree. 
CART can analyze the data and reveal the importance of each explanatory variable. CART 
also has some weaknesses. For example, the split of data into subgroups is only based on a 
single explanatory variable, and there is no probability level or confidence interval for 
predictions obtained from a CART tree. (11; 12) 
 
Figure 2-2 A classification and regression tree built on dataset of kyphosis (13) 
 
  
|
Start>=8.5
Start>=14.5
Age< 55
Age>=111
absent 
29/0 absent 
12/0
absent 
12/2
present
3/4
present
8/11
|
11 
 
Chapter 3 - Assessing Diagnostic Test for Breast Cancer (CathB) 
 3.1 Overview of the data 
There are two groups in the dataset. The first group includes 20 patients with breast cancer 
at different stages (0, I, II, III, IV), and the second group includes 12 individuals who do not 
have cancer. The second group is called the control group. Each individual was asked to 
provide personal information, including age and stage of cancer. The nanoparticles added 
to the blood samples are coated with Cathepsin B, which is a type of protein to interact with 
the enzyme in the blood samples. The level of CathB (enzyme activity) was tested three 
times. The average level of CathB is computed and used as the random variable to predict 
level of breast cancer. Relationships between any two variables are displayed in Figure 3-1, 
Figure 3-2 and Figure 3-3. From these boxplots, it can be seen that patients with cancer 
stages of III and IV have higher average CathB than the persons without breast cancer or 
the patients with breast cancer of stage 0, I, and II. Age of patient does not show a 
significant relationship with average CathB. But age of patient seems to have a relationship 
with stages of breast cancer; patients with breast cancer of stage I, II, III, and IV are older 
than the persons without breast cancer or with breast cancer of stage 0. 
 
Figure 3-1 Relationship between average CathB and staging of cancer 
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Figure 3-2 Relationship between average CathB and age 
 
Figure 3-3 Relationship between age and staging of cancer 
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 3.2 Comparison of three measurements  
The enzyme pattern of each person was tested three times on different days. Figure 3-4 
shows the results of the three measurements. It can be seen that the experimental error is 
very small. In addition, a logistic regression model is used to predict the probability of 
having severe breast cancer for each person by using the individual enzyme pattern instead 
of the average enzyme pattern of the three measurements. Severe breast cancer includes 
breast cancer of stages III and IV. Moderate breast cancer includes breast cancer of stages 0, 
I, II and no breast cancer. The reason why the patients are grouped into “moderate breast 
cancer” group and “severe breast cancer” group is because from the boxplot of breast 
cancer staging vs enzyme pattern, it can be seen that patients having breast cancer of stage 
III and IV have higher enzyme activity than patients having breast cancer of stage 0, I, and II. 
This grouping also allows use of all observations in this initial analysis to investigate the 
consistency of the three measurements. Later, other groupings will be used when 
evaluating the sensitivity of the test for distinguishing stages of cancer. In addition, logistic 
regression requires the response to be binary. So the patients are separated into two groups. 
The probabilities of having severe breast cancer for each patient are listed in Table 3-1, 
showing that there is no significant difference between the three probabilities. The three 
probabilities for each person are also shown in Figure 3-5. As a result, in this report, the 
models are built based on the average value of three measurements. 
 
Figure 3-4 Comparison of the three enzyme patterns of different individuals 
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Table 3-1 Probabilities of severe cancer for each patient predicted by logistic 
regression, calculated separately for three measurements 
Obs Patient Age Staging level P1 P2 P3 
1 B1 41 0 moderate 0.091  0.180  0.187  
2 B10 59 II moderate 0.380  0.384  0.414  
3 B11 46 III severe 0.025  0.026  0.030  
4 B12 62 IV severe 0.823  0.772  0.756  
5 B13 40 IV severe 0.888  0.856  0.798  
6 B14 40 II moderate 0.056  0.045  0.066  
7 B15 36 III severe 0.993  0.991  0.995  
8 B16 53 IV severe 0.996  0.996  0.997  
9 B17 52 III severe 0.972  0.972  0.988  
10 B18 43 IV severe 0.940  0.930  0.978  
11 B19 51 II moderate 0.019  0.020  0.022  
12 B2 64 IV severe 0.812  0.851  0.877  
13 B20 80 III severe 0.840  0.829  0.857  
14 B3 45 0 moderate 0.006  0.005  0.007  
15 B4 59 I moderate 0.041  0.041  0.034  
16 B5 65 III severe 0.758  0.799  0.787  
17 B6 77 IV severe 1.000  1.000  1.000  
18 B6a 81 I moderate 0.191  0.182  0.156  
19 B7 78 IV severe 0.997  0.998  0.997  
20 B8 75 III severe 0.993  0.995  0.993  
21 C1 47 C moderate 0.201  0.148  0.132  
22 C10 60 C moderate 0.036  0.035  0.035  
23 C11 26 C moderate 0.001  0.002  0.003  
24 C12 44 C moderate 0.011  0.015  0.014  
25 C2 51 C moderate 0.642  0.664  0.630  
26 C3 28 C moderate 0.007  0.008  0.010  
27 C4 32 C moderate 0.014  0.012  0.019  
28 C5 62 C moderate 0.033  0.033  0.033  
29 C6 48 C moderate 0.139  0.118  0.152  
30 C7 49 C moderate 0.077  0.073  0.004  
31 C8 26 C moderate 0.002  0.002  0.002  
32 C9 42 C moderate 0.022  0.021  0.023 
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Figure 3-5 Scatterplot of severe cancer probabilities for each patient predicted by 
logistic regression using individual enzyme pattern as the predictor 
 
 
 3.3Analysis based on logistic regression with binary response (stage 0 
and I deleted) 
 3.3.1 Use of average CathB as the predictor 
A logistic regression model is used to predict the probability of having breast cancer for 
each person. Patients with breast cancer of staging II, III, and IV are grouped together as 
having breast cancer, whereas the persons without breast cancer are grouped together as 
having no breast cancer. Patients with breast cancer of stage 0 or I are deleted because they 
have very low enzyme activity although they have breast cancer. By deleting these stages, 
the model will have less error and has a better prediction on the existence of breast cancer 
at later stages II, III, and IV. There are only 2 persons having breast cancer of stage 0 and 2 
persons having breast cancer of stage I.  Only 4 persons are deleted. When average CathB is 
used as the predictor, the estimates of parameters are shown in Table 3-2. Probability of 
having breast cancer for each patient is shown in Table 3-3. 
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Table 3-2 Analysis of Maximum Likelihood Estimates 
Standard             Wald 
     Parameter    DF    Estimate     Error      Chi-Square    Pr > ChiSq 
     Intercept     1     -2.8809      1.1731        6.0314           0.0141 
     CathB        1    2.532E-6    9.857E-7        6.5954          0.0102 
 
Table 3-3 Probability of having breast cancer for each patient 
Obs Patient Age Staging CathB Cancer Prob 
1 C1 47 C 1220798 No 0.552  
2 C2 51 C 1785704 No 0.838  
3 C3 28 C 806983.7 No 0.302  
4 C4 32 C 873253.3 No 0.339  
5 C5 62 C 313112.3 No 0.110  
6 C6 48 C 1140311 No 0.502  
7 C7 49 C 627024.3 No 0.215  
8 C8 26 C 428675.7 No 0.142  
9 C9 42 C 720771.7 No 0.258  
10 C10 60 C 387576 No 0.130  
11 C11 26 C 420150.7 No 0.140  
12 C12 44 C 515214.7 No 0.171  
13 B10 59 II 1264716 Yes 0.580  
14 B14 40 II 1060055 Yes 0.451  
15 B19 51 II 456155 Yes 0.151  
16 B5 65 III 1611268 Yes 0.768  
17 B8 75 III 2473030 Yes 0.967  
18 B11 46 III 677698.3 Yes 0.238  
19 B15 36 III 3481133 Yes 0.997  
20 B17 52 III 2723205 Yes 0.982  
21 B20 80 III 1327514 Yes 0.618  
22 B2 64 IV 1770087 Yes 0.832  
23 B6 77 IV 3335243 Yes 0.996  
24 B7 78 IV 2626708 Yes 0.977  
25 B12 62 IV 1697287 Yes 0.805  
26 B13 40 IV 2419770 Yes 0.963  
27 B16 53 IV 3226621 Yes 0.995  
28 B18 43 IV 2720022 Yes 0.982  
 
The optimal cut-off probability to predict if a person has breast cancer is found by a ROC 
curve. The ROC curve is obtained by plotting sensitivity and 1-specificity for different cut-
off values. Table 3-4 lists sensitivity and 1-specificity calculated under different cut-off 
values and Figure 3-6 is the ROC curve. The optimal point is the one which has the smallest 
distance to the point (0, 1) and at the same time has the largest vertical distance to the line 
of equality. Based on these criteria, the probability of 0.580 is the optimal cut-off 
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probability to predict if the person has breast cancer. If the predicted probability of a 
person is above 0.580, this person is predicted to have breast cancer. If the predicted 
probability of a person is below 0.580, this person is predicted to have no breast cancer. 
The area under the ROC curve is 0.8854, indicating this test method is good, but not 
excellent. 
Figure 3-6 ROC curve of the model 
 
 
Table 3-4 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 0.997  0.06  0.00  0.94  0.06  
2 0.996  0.13  0.00  0.88  0.13  
3 0.995  0.19  0.00  0.81  0.19  
4 0.982  0.25  0.00  0.75  0.25  
5 0.982  0.31  0.00  0.69  0.31  
6 0.977  0.38  0.00  0.63  0.38  
7 0.967  0.44  0.00  0.56  0.44  
8 0.962  0.50  0.00  0.50  0.50  
9 0.837  0.50  0.08  0.51  0.42  
10 0.832  0.56  0.08  0.45  0.48  
11 0.805  0.63  0.08  0.38  0.54  
12 0.768  0.69  0.08  0.32  0.60  
13 0.618  0.75  0.08  0.26  0.67  
14 0.580  0.81  0.08  0.21  0.73  
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15 0.552  0.81  0.17  0.25  0.65  
16 0.501  0.81  0.25  0.31  0.56  
17 0.451  0.88  0.25  0.28  0.63  
18 0.338  0.88  0.33  0.36  0.54  
19 0.302  0.88  0.42  0.44  0.46  
20 0.258  0.88  0.50  0.52  0.38  
21 0.238  0.94  0.50  0.50  0.44  
22 0.215  0.94  0.58  0.59  0.35  
23 0.171  0.94  0.67  0.67  0.27  
24 0.151  1.00  0.67  0.67  0.33  
25 0.142  1.00  0.75  0.75  0.25  
26 0.140  1.00  0.83  0.83  0.17  
27 0.130  1.00  0.92  0.92  0.08  
28 0.110  1.00  1.00  1.00  0.00  
 
When the cut-off probability is set to be 0.580, the relationship between the predicted 
existence of breast cancer and the actual diagnosis is shown in Figure 3-7. One person 
without breast cancer is predicted to have breast cancer, whereas, three persons with 
breast cancer are predicted to have no breast cancer. The sensitivity and specificity for this 
test is 0.81 and 0.92, respectively. Table 3-5 summarizes how many persons are predicted 
to have breast cancer and how many persons are predicted to have no breast cancer for 
patients in different stages of breast cancer. 
 
Figure 3-7 Prediction of existence of cancer based on the optimal cut-off probability 
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Table 3-5 Prediction of existence of breast cancer for patients in different stages of 
breast cancer 
  Predicted 
  No Yes 
C 11 1 
II 2 1 
III 1 5 
IV 0 7 
 
 3.3.2 Use of average CathB and age as the predictor 
In this section, average CathB and age are used as the predictors to predict if the person has 
breast cancer. Estimates of parameters are shown in Table 3-6. The probability of having 
breast cancer for each patient is shown in Table 3-7. 
Table 3-6 Analysis of Maximum Likelihood Estimates 
                                                                                  Standard           Wald 
   Parameter    DF   Estimate      Error        Chi-Square  Pr > ChiSq 
   Intercept       1     -6.2938         2.8811        4.7720       0.0289 
   CathB             1      2.073E-6      8.738E-7    5.6290       0.0177 
   Age                 1       0.0785         0.0536         2.1440       0.1431 
 
Table 3-7 Probability of having breast cancer for each patient 
Obs Patient Age Staging CathB Cancer Prob 
1 B2 64 IV 1770087 Yes 0.917  
2 B5 65 III 1611268 Yes 0.896  
3 B6 77 IV 3335243 Yes 0.999  
4 B7 78 IV 2626708 Yes 0.995  
5 B8 75 III 2473030 Yes 0.991  
6 B10 59 II 1264716 Yes 0.723  
7 B11 46 III 677698.3 Yes 0.218  
8 B12 62 IV 1697287 Yes 0.890  
9 B13 40 IV 2419770 Yes 0.866  
10 B14 40 II 1060055 Yes 0.278  
11 B15 36 III 3481133 Yes 0.977  
12 B16 53 IV 3226621 Yes 0.990  
13 B17 52 III 2723205 Yes 0.969  
14 B18 43 IV 2720022 Yes 0.938  
15 B19 51 II 456155 Yes 0.207  
16 B20 80 III 1327514 Yes 0.939  
17 C1 47 C 1220798 No 0.482  
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18 C2 51 C 1785704 No 0.804  
19 C3 28 C 806983.7 No 0.081  
20 C4 32 C 873253.3 No 0.122  
21 C5 62 C 313112.3 No 0.315  
22 C6 48 C 1140311 No 0.460  
23 C7 49 C 627024.3 No 0.241  
24 C8 26 C 428675.7 No 0.033  
25 C9 42 C 720771.7 No 0.182  
26 C10 60 C 387576 No 0.314  
27 C11 26 C 420150.7 No 0.033  
28 C12 44 C 515214.7 No 0.145  
 
Table 3-8 lists sensitivity and 1-specificity calculated under different cut-off probabilities 
and Figure 3-8 is the ROC curve. From Table 3-8, it is found that 0.723 is the optimal cut-off 
probability to predict if a person has breast cancer or not. If the predicted probability of a 
person is above 0.723, this person is predicted to have breast cancer. If the predicted 
probability of a person is below 0.723, this person is predicted to have no breast cancer. 
The area under the ROC curve is 0.9063, indicating this test method is excellent. 
 
Figure 3-8 ROC curve of the model 
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Table 3-8 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) 
Youden 
index 
1 0.999  0.06  0.00  0.94 0.06 
2 0.995  0.13  0.00  0.88 0.13 
3 0.991  0.19  0.00  0.81 0.19 
4 0.990  0.25  0.00  0.75 0.25 
5 0.977  0.31  0.00  0.69 0.31 
6 0.969  0.38  0.00  0.63 0.38 
7 0.939  0.44  0.00  0.56 0.44 
8 0.938  0.50  0.00  0.50 0.50 
9 0.917  0.56  0.00  0.44 0.56 
10 0.895  0.63  0.00  0.38 0.63 
11 0.890  0.69  0.00  0.31 0.69 
12 0.865  0.75  0.00  0.25 0.75 
13 0.804  0.75  0.08  0.26 0.67 
14 0.723  0.81  0.08  0.21 0.73 
15 0.481  0.81  0.17  0.25 0.65 
16 0.459  0.81  0.25  0.31 0.56 
17 0.314  0.81  0.33  0.38 0.48 
18 0.314  0.81  0.42  0.46 0.40 
19 0.277  0.88  0.42  0.44 0.46 
20 0.241  0.88  0.50  0.52 0.38 
21 0.218  0.94  0.50  0.50 0.44 
22 0.207  1.00  0.50  0.50 0.50 
23 0.182  1.00  0.58  0.58 0.42 
24 0.145  1.00  0.67  0.67 0.33 
25 0.122  1.00  0.75  0.75 0.25 
26 0.081  1.00  0.83  0.83 0.17 
27 0.033  1.00  0.92  0.92 0.08 
28 0.033  1.00  1.00  1.00 0.00 
 
When the cut-off probability is set to be 0.723, the relationship between the predicted 
existence of breast cancer and the actual diagnosis is shown in Figure 3-9. One person 
without breast cancer is predicted to have breast cancer, whereas, three persons with 
breast cancer are predicted to have no cancer. The sensitivity and specificity for this test is 
0.81 and 0.92, respectively. Table 3-9 summarizes how many persons are predicted to have 
breast cancer and how many persons are predicted to have no breast cancer for patients at 
different stages of breast cancer. 
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Table 3-9 Prediction of existence of breast cancer for patients at different stages 
  Predicted 
  No Yes 
C 11 1 
II 2 1 
III 1 5 
IV 0 7 
 
Figure 3-9 Prediction of existence of cancer based on the optimal cut-off probability 
 
 
 3.3.3 Comparison of models in section 3.3.1 and 3.3.2 
Table 3-10 compares the probabilities calculated by the models in section 3.3.1 (average 
CathB is used as the predictor) and section 3.3.2 (average CathB and age are used as the 
predictors). The probabilities do not have a big difference for most of the persons. The 
maximum difference is 0.321, showing up on patient B20 with a cancer stage III. If the age 
of a patient is close to the average age of the persons involved in the test, the difference 
between the two probabilities is smaller. If the age of a patient is very different from the 
average age, the difference between the two probabilities is big. 
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Table 3-10 Comparison of probabilities of having breast cancer for each patient 
between the two models in section 3.3.1 and 3.3.2 
Obs Patient Age Staging CathB Cancer Prob1 Prob2 
13 B10 59 II 1264716 Yes 0.580  0.723  
18 B11 46 III 677698.3 Yes 0.238  0.218  
25 B12 62 IV 1697287 Yes 0.805  0.890  
26 B13 40 IV 2419770 Yes 0.963  0.866  
14 B14 40 II 1060055 Yes 0.451  0.278  
19 B15 36 III 3481133 Yes 0.997  0.977  
27 B16 53 IV 3226621 Yes 0.995  0.990  
20 B17 52 III 2723205 Yes 0.982  0.969  
28 B18 43 IV 2720022 Yes 0.982  0.938  
15 B19 51 II 456155 Yes 0.151  0.207  
22 B2 64 IV 1770087 Yes 0.832  0.917  
21 B20 80 III 1327514 Yes 0.618  0.939  
16 B5 65 III 1611268 Yes 0.768  0.896  
23 B6 77 IV 3335243 Yes 0.996  0.999  
24 B7 78 IV 2626708 Yes 0.977  0.995  
17 B8 75 III 2473030 Yes 0.967  0.991  
1 C1 47 C 1220798 No 0.552  0.482  
10 C10 60 C 387576 No 0.130  0.314  
11 C11 26 C 420150.7 No 0.140  0.033  
12 C12 44 C 515214.7 No 0.171  0.145  
2 C2 51 C 1785704 No 0.838  0.804  
3 C3 28 C 806983.7 No 0.302  0.081  
4 C4 32 C 873253.3 No 0.339  0.122  
5 C5 62 C 313112.3 No 0.110  0.315  
6 C6 48 C 1140311 No 0.502  0.460  
7 C7 49 C 627024.3 No 0.215  0.241  
8 C8 26 C 428675.7 No 0.142  0.033  
9 C9 42 C 720771.7 No 0.258  0.182  
 
Table 3-11 summarizes the differences of the two models in the diagnostic test of breast 
cancer. Including age as a predictor increases the area under the ROC curve, increases the 
cut-off probability, but does not change sensitivity and specificity of the test. The p-value 
for predictor average CathB is increased. The p-value for the predictor age is 0.1431, 
indicating that age has a marginal influence on the prediction. Comparison of predicted 
accuracy between the two models is shown in Figure 3-10.  
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Table 3-11 Comparison of models in section 3.3.1 and 3.3.2 
Predictor Area under the   Threshold Sensi Speci P-value 
   ROC curve       MMP Age 
Average CathB 0.8854 0.580 0.81 0.92 0.0102 N/A 
Average 
CathB+Age 
0.9063 0.723 0.81 0.92 0.0177 0.1431 
 
 
Figure 3-10 Prediction of existence of breast cancer based on the optimal cut-off 
probability for the models used in section 3.3.1 and 3.3.2 
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cancer condition is severe. All the other individuals belong to the moderate group(control 
and stage 0 and I). The reason for division of patients into such two groups is explained in 
section 3.2. The individuals with breast cancer of stage II are deleted. The reason why they 
are deleted is because breast cancer of stage II is more advanced, but patients having breast 
cancer of stage II have much lower enzyme activity than the patients having breast cancer 
of stage III and IV. By deleting stage II, the model will have less error and has a better 
prediction on the existence of severe breast cancer. There are only 3 persons having breast 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Predictor: AverageCathB 
         
 Predictor: AverageCathB and Age
 Predictor: AverageCathB 
P
ro
ba
bi
li
ty
 o
f 
br
ea
st
 c
an
ce
r
Existence of breast cancer
No Yes
Predictor: AverageCathB 
                and Age
 
 
25 
 
cancer of stage II. Then the number of individuals in this analysis becomes 29. The different 
groupings done here in addition to what was done in earlier subsections should improve 
insight into the performance capabilities of the test in distinguishing stages of cancer. 
Confidence interval for the probabilities of having severe breast cancer are calculated in 
section 3.41 and used as an example to show how to calculate confidence intervals and how 
to use confidence intervals. Due to complexity, confidence intervals are not calculated in 
other sections. 
 3.4.1 Use of average CathB as the predictor  
When average CathB is used as the predictor, the estimates of parameters are shown in 
Table 3-12. The predicted probability of severe breast cancer and 95% confidence interval 
of the probability are listed in Table 3-13.  
 
Table 3-12 Analysis of Maximum Likelihood Estimates 
Standard              Wald 
  Parameter    DF    Estimate       Error           Chi-Square    Pr > ChiSq 
  Intercept      1      -4.8059          1.7494        7.5468            0.0060 
  CathB            1        3.381E-6     1.259E-6     7.2130            0.0072 
 
Table 3-13 Probability of having severe breast cancer for each person 
Obs Patient Staging CathB Level Prob L-Prob U-Prob 
1 C1 C 1220798 moderate 0.337  0.124  0.645  
2 C2 C 1785704 moderate 0.774  0.370  0.952  
3 C3 C 806983.7 moderate 0.111  0.022  0.416  
4 C4 C 873253.3 moderate 0.135  0.030  0.445  
5 C5 C 313112.3 moderate 0.023  0.002  0.265  
6 C6 C 1140311 moderate 0.279  0.094  0.591  
7 C7 C 627024.3 moderate 0.064  0.009  0.351  
8 C8 C 428675.7 moderate 0.034  0.003  0.293  
9 C9 C 720771.7 moderate 0.086  0.014  0.383  
10 C10 C 387576 moderate 0.029  0.002  0.282  
11 C11 C 420150.7 moderate 0.033  0.003  0.291  
12 C12 C 515214.7 moderate 0.045  0.005  0.317  
13 B1 0 1353355 moderate 0.443  0.181  0.740  
14 B3 0 254411 moderate 0.019  0.001  0.251  
15 B4 I 442882.7 moderate 0.035  0.003  0.297  
16 B6a I 347228.3 moderate 0.026  0.002  0.273  
17 B5 III 1611268 severe 0.655  0.299  0.894  
18 B8 III 2473030 severe 0.972  0.591  0.999  
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19 B11 III 677698.3 severe 0.075  0.011  0.368  
20 B15 III 3481133 severe 0.999  0.802  1.000  
21 B17 III 2723205 severe 0.988  0.654  1.000  
22 B20 III 1327514 severe 0.421  0.170  0.722  
23 B2 IV 1770087 severe 0.765  0.364  0.949  
24 B6 IV 3335243 severe 0.998  0.779  1.000  
25 B7 IV 2626708 severe 0.983  0.631  1.000  
26 B12 IV 1697287 severe 0.718  0.335  0.928  
27 B13 IV 2419770 severe 0.967  0.576  0.998  
28 B16 IV 3226621 severe 0.998  0.760  1.000  
29 B18 IV 2720022 severe 0.988  0.654  1.000  
 
The optimal cut-off probability to predict if the person has severe breast cancer is found by 
a ROC curve. Table 3-14 lists sensitivity and 1-specificity calculated under different cut-off 
probabilities and Figure 3-11 is the ROC curve. The optimal point is the one which has the 
smallest distance to the point (0, 1) and at the same time has the largest vertical distance to 
the line of equality. Based on these criteria, the probability of 0.421 is the optimal cut-off 
probability to predict if the person has severe breast cancer. If the predicted probability of a 
person is above 0.421, this person is predicted to have severe breast cancer. If the predicted 
probability of a person is below 0.421, this person is predicted to have moderate breast 
cancer. The area under the ROC curve is 0.9423, indicating this test method is excellent. 
Figure 3-11 ROC curve of the model 
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Table 3-14 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden Index 
1 0.999  0.08  0.00  0.92  0.08 
2 0.998  0.15  0.00  0.85  0.15 
3 0.998  0.23  0.00  0.77  0.23 
4 0.988  0.31  0.00  0.69  0.31 
5 0.988  0.38  0.00  0.62  0.38 
6 0.983  0.46  0.00  0.54  0.46 
7 0.972  0.54  0.00  0.46  0.54 
8 0.967  0.62  0.00  0.38  0.62 
9 0.774  0.62  0.06  0.39  0.56 
10 0.765  0.69  0.06  0.31  0.63 
11 0.718  0.77  0.06  0.24  0.71 
12 0.655  0.85  0.06  0.17  0.79 
13 0.443  0.85  0.13  0.20  0.72 
14 0.421  0.92  0.13  0.15  0.79 
15 0.337  0.92  0.19  0.20  0.73 
16 0.279  0.92  0.25  0.26  0.67 
17 0.136  0.92  0.31  0.32  0.61 
18 0.111  0.92  0.38  0.38  0.54 
19 0.086  0.92  0.44  0.44  0.48 
20 0.075  1.00  0.44  0.44  0.56 
21 0.064  1.00  0.50  0.50  0.5 
22 0.045  1.00  0.56  0.56  0.44 
23 0.035  1.00  0.63  0.63  0.37 
24 0.034  1.00  0.69  0.69  0.31 
25 0.033  1.00  0.75  0.75  0.25 
26 0.029  1.00  0.81  0.81  0.19 
27 0.026  1.00  0.88  0.88  0.12 
28 0.023  1.00  0.94  0.94  0.06 
29 0.019  1.00  1.00  1.00  0.00 
 
The relationship between the predicted probability of severe breast cancer and severity of 
breast cancer is shown in Figure 3-12. From Figure 3-12, it can be seen that if 0.421 is set as 
the threshold for the prediction of severe breast cancer, two patients with moderate breast 
cancer condition are predicted to have severe breast cancer, while one patient with severe 
breast cancer condition is predicted to have moderate breast cancer. Figure 3-13 shows the 
confidence interval for the probability of having breast cancer for each person. There is 
only one patient with severe breast cancer, which has a confidence interval below 0.421. 
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For the two patients who have moderate breast cancer condition but predicted to have 
severe breast cancer, the lower bounds of confidence intervals for probabilities of having 
severe breast cancer are smaller than 0.421. This figure is shown here to illustrate the 
uncertainty in estimated probabilities. It is not repeated elsewhere since small sample sizes 
used here produce wide intervals. Future analyses with large datasets will yield more 
useable interval estimates. 
 
The sensitivity and specificity for this test are 0.92 and 0.87, respectively. Table 3-15 
summarizes how many persons are predicted to have severe breast cancer and how many 
persons are predicted to have moderate breast cancer for patients at different stages. 
 
Figure 3-12 Prediction of existence of cancer based on the optimal cut-off probability 
 
Table 3-15 Prediction of severity of breast cancer for patients in different stages 
  Predicted 
  Moderate Severe 
C 11 1 
0 1 1 
I 2 0 
III 1 5 
IV 0 7 
 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
P
ro
b
ab
il
it
y 
o
f 
se
ve
re
 c
an
ce
r
Severity of breast cancer
Moderate Severe
 
 
29 
 
Figure 3-13 Confidence interval of probability of having breast cancer for each 
patient 
 
 
 3.4.2 Use of average CathB and age as the predictor  
In this section, average CathB and age are used as the predictors to predict if the person has 
severe breast cancer. Estimates of parameters are shown in Table 3-16. Probability of 
having breast cancer for each patient is shown in Table 3-17. 
 
Table 3-16 Analysis of Maximum Likelihood Estimates 
                                                                                   Standard              Wald 
 Parameter    DF    Estimate       Error          Chi-Square    Pr > ChiSq 
 Intercept       1     -9.4669          4.0254        5.5309            0.0187 
 CathB             1       3.254E-6      1.189E-6    7.4885            0.0062 
                         Age                 1       0.0879          0.0564        2.4336             0.1188 
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Table 3-17 Probability of having breast cancer for each patient 
Obs Patient Age Staging CathB level probability 
1 B1 41 0 1353355 moderate 0.189  
2 B2 64 IV 1770087 severe 0.872  
3 B3 45 0 254411 moderate 0.009  
4 B4 59 I 442882.7 moderate 0.055  
5 B5 65 III 1611268 severe 0.816  
6 B6 77 IV 3335243 severe 1.000  
7 B6a 81 I 347228.3 moderate 0.228  
8 B7 78 IV 2626708 severe 0.997  
9 B8 75 III 2473030 severe 0.994  
10 B11 46 III 677698.3 severe 0.038  
11 B12 62 IV 1697287 severe 0.818  
12 B13 40 IV 2419770 severe 0.872  
13 B15 36 III 3481133 severe 0.993  
14 B16 53 IV 3226621 severe 0.997  
15 B17 52 III 2723205 severe 0.981  
16 B18 43 IV 2720022 severe 0.959  
17 B20 80 III 1327514 severe 0.868  
18 C1 47 C 1220798 moderate 0.204  
19 C2 51 C 1785704 moderate 0.696  
20 C3 28 C 806983.7 moderate 0.012  
21 C4 32 C 873253.3 moderate 0.022  
22 C5 62 C 313112.3 moderate 0.048  
23 C6 48 C 1140311 moderate 0.177  
24 C7 49 C 627024.3 moderate 0.042  
25 C8 26 C 428675.7 moderate 0.003  
26 C9 42 C 720771.7 moderate 0.031  
27 C10 60 C 387576 moderate 0.051  
28 C11 26 C 420150.7 moderate 0.003  
29 C12 44 C 515214.7 moderate 0.019  
  
Table 3-18 lists sensitivity and 1-specificity calculated under different cut-off probabilities 
and Figure 3-14 is the ROC curve. From Table 3-18, it is found that 0.816 is the optimal cut-
off probability to predict if the person has severe breast cancer. If the predicted probability 
of a person is above 0.816, this person is predicted to have severe breast cancer. If the 
predicted probability of a person is below 0.816, this person is predicted to have moderate 
breast cancer. The area under the ROC curve is 0.9567, indicating this test method is 
excellent. 
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Figure 3-14 ROC curve of the model 
 
 
Table 3-18 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0,1), and Youden index 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 1.000  0.08  0.00  0.92  0.08 
2 0.997  0.15  0.00  0.85  0.15 
3 0.997  0.23  0.00  0.77  0.23 
4 0.994  0.31  0.00  0.69  0.31 
5 0.993  0.38  0.00  0.62  0.38 
6 0.981  0.46  0.00  0.54  0.46 
7 0.959  0.54  0.00  0.46  0.54 
8 0.873  0.62  0.00  0.38  0.62 
9 0.872  0.69  0.00  0.31  0.69 
10 0.868  0.77  0.00  0.23  0.77 
11 0.819  0.85  0.00  0.15  0.85 
12 0.816  0.92  0.00  0.08  0.92 
13 0.696  0.92  0.06  0.10  0.86 
14 0.229  0.92  0.13  0.15  0.79 
15 0.204  0.92  0.19  0.20  0.73 
16 0.189  0.92  0.25  0.26  0.67 
17 0.177  0.92  0.31  0.32  0.61 
18 0.055  0.92  0.38  0.38  0.54 
19 0.051  0.92  0.44  0.44  0.48 
20 0.048  0.92  0.50  0.51  0.42 
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21 0.042  0.92  0.56  0.57  0.36 
22 0.039  1.00  0.56  0.56  0.44 
23 0.031  1.00  0.63  0.63  0.37 
24 0.022  1.00  0.69  0.69  0.31 
25 0.019  1.00  0.75  0.75  0.25 
26 0.012  1.00  0.81  0.81  0.19 
27 0.009  1.00  0.88  0.88  0.12 
28 0.003  1.00  0.94  0.94  0.06 
29 0.003  1.00  1.00  1.00  0 
 
When the cut-off probability is set to be 0.816, the relationship between the predicted 
existence of severe breast cancer and the actual diagnosis is shown in Figure 3-15. No 
patient with moderate breast cancer condition is predicted to have severe breast cancer, 
while one patient with severe breast cancer condition is predicted to have moderate breast 
cancer. The sensitivity and specificity for this test is 0. 92 and 1.00, respectively. Table 3-19 
summarizes how many persons are predicted to have severe breast cancer and how many 
persons are predicted to have moderate breast cancer for patients at different stages. 
 
Figure 3-15 Prediction of existence of cancer based on the optimal cut-off probability 
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Table 3-19 Prediction of severity of breast cancer for patients at different stages of 
breast cancer 
  Predicted 
  Moderate Severe 
C 12 0 
0 2 0 
I 2 0 
III 1 5 
IV 0 7 
 
 3.4.3 Comparison of models in section 3.4.1 and 3.4.2 
Probabilities computed in section 3.4.1 and section 3.4.2 are presented in Table 3-20. From 
Table 3-20, it can be seen that the probabilities calculated are quite similar for the persons 
whose ages are far from the average age of the persons involved in the test. But for the 
persons whose ages are close to the average age, the difference between the two 
probabilities is big. Comparison of the predicted results is shown in Figure 3-16. Including 
of age predictor increases the area under the ROC curve and increases sensitivity and 
specificity. 
 
Table 3-20 Comparison of probabilities of having breast cancer for each patient 
between the two models in section 3.4.1 and 3.4.2 
Obs Patient Staging CathB level Prob1 Age Prob2 
1 B1 0 1353355 moderate 0.443  41 0.189  
2 B11 III 677698.3 severe 0.075  46 0.038  
3 B12 IV 1697287 severe 0.718  62 0.818  
4 B13 IV 2419770 severe 0.967  40 0.872  
5 B15 III 3481133 severe 0.999  36 0.993  
6 B16 IV 3226621 severe 0.998  53 0.997  
7 B17 III 2723205 severe 0.988  52 0.981  
8 B18 IV 2720022 severe 0.988  43 0.959  
9 B2 IV 1770087 severe 0.765  64 0.872  
10 B20 III 1327514 severe 0.421  80 0.868  
11 B3 0 254411 moderate 0.019  45 0.009  
12 B4 I 442882.7 moderate 0.035  59 0.055  
13 B5 III 1611268 severe 0.655  65 0.816  
14 B6 IV 3335243 severe 0.998  77 1.000  
15 B6a I 347228.3 moderate 0.026  81 0.228  
16 B7 IV 2626708 severe 0.983  78 0.997  
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17 B8 III 2473030 severe 0.972  75 0.994  
18 C1 C 1220798 moderate 0.337  47 0.204  
19 C10 C 387576 moderate 0.029  60 0.051  
20 C11 C 420150.7 moderate 0.033  26 0.003  
21 C12 C 515214.7 moderate 0.045  44 0.019  
22 C2 C 1785704 moderate 0.774  51 0.696  
23 C3 C 806983.7 moderate 0.111  28 0.012  
24 C4 C 873253.3 moderate 0.135  32 0.022  
25 C5 C 313112.3 moderate 0.023  62 0.048  
26 C6 C 1140311 moderate 0.279  48 0.177  
27 C7 C 627024.3 moderate 0.064  49 0.042  
28 C8 C 428675.7 moderate 0.034  26 0.003  
29 C9 C 720771.7 moderate 0.086  42 0.031  
 
Figure 3-16 Prediction of existence of cancer based on the optimal cut-off probability 
for the models used in section 3.4.1 and 3.4.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.5 Analysis based on logistic regression with binary response 
(complete data) 
As one last grouping, patients at stage III and IV are group together and their breast cancer 
condition is severe. All the other individuals belong to the control group, and their breast 
cancer condition is denoted as moderate. The reason for division of patients into such two 
groups is explained in section 3.2, and is done here to make use of all samples. 
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 3.5.1 Use of average CathB is used as the predictor 
When average CathB is used as the predictor, the estimates of parameters are shown in 
Table 3-21. The predicted probability of severe breast cancer for each person is listed in 
Table 3-22. 
 
Table 3-21 Analysis of Maximum Likelihood Estimates 
Standard      Wald 
Parameter    DF    Estimate       Error         Chi-Square  Pr > ChiSq 
Intercept     1       -5.2329          1.8366        8.1178        0.0044 
CathB           1         3.535E-6      1.308E-6    7.3004        0.0069 
 
Table 3-22 Probability of having breast cancer for each patient 
Obs Patient Staging CathB Level Prob 
1 C1 C 1220798 moderate 0.285  
2 C2 C 1785704 moderate 0.746  
3 C3 C 806983.7 moderate 0.085  
4 C4 C 873253.3 moderate 0.105  
5 C5 C 313112.3 moderate 0.016  
6 C6 C 1140311 moderate 0.231  
7 C7 C 627024.3 moderate 0.047  
8 C8 C 428675.7 moderate 0.024  
9 C9 C 720771.7 moderate 0.064  
10 C10 C 387576 moderate 0.021  
11 C11 C 420150.7 moderate 0.023  
12 C12 C 515214.7 moderate 0.032  
13 B1 0 1353355 moderate 0.390  
14 B3 0 254411 moderate 0.013  
15 B4 I 442882.7 moderate 0.025  
16 B6a I 347228.3 moderate 0.018  
17 B10 II 1264716 moderate 0.318  
18 B14 II 1060055 moderate 0.185  
19 B19 II 456155 moderate 0.026  
20 B5 III 1611268 severe 0.614  
21 B8 III 2473030 severe 0.971  
22 B11 III 677698.3 severe 0.055  
23 B15 III 3481133 severe 0.999  
24 B17 III 2723205 severe 0.988  
25 B20 III 1327514 severe 0.368  
26 B2 IV 1770087 severe 0.736  
27 B6 IV 3335243 severe 0.999  
28 B7 IV 2626708 severe 0.983  
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29 B12 IV 1697287 severe 0.683  
30 B13 IV 2419770 severe 0.965  
31 B16 IV 3226621 severe 0.998  
32 B18 IV 2720022 severe 0.988  
 
The optimal cut-off probability to predict if the person has severe breast cancer is found by 
a ROC curve. Table 3-23 lists sensitivity and 1-specificity calculated under different cut-off 
probabilities and Figure 3-17 is the ROC curve. The optimal point is, again the one which 
has the smallest distance to the point (0, 1) and at the same time has the largest vertical 
distance to the line of equality. Based on these criteria, the probability of 0.368 is the 
optimal cut-off probability to predict if the person has severe breast cancer. If the predicted 
probability of a person is above 0.368, this person is predicted to have severe breast cancer. 
If the predicted probability of a person is below 0.368, this person is predicted to have 
moderate breast cancer. The area under the ROC curve is 0.9433, indicating this test 
method is excellent. 
Figure 3-17 ROC curve of the model 
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Table 3-23 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 0.999  0.08  0.00  0.92  0.08 
2 0.999  0.15  0.00  0.85  0.15 
3 0.998  0.23  0.00  0.77  0.23 
4 0.988  0.31  0.00  0.69  0.31 
5 0.988  0.38  0.00  0.62  0.38 
6 0.983  0.46  0.00  0.54  0.46 
7 0.971  0.54  0.00  0.46  0.54 
8 0.965  0.62  0.00  0.38  0.62 
9 0.747  0.62  0.05  0.39  0.57 
10 0.736  0.69  0.05  0.31  0.64 
11 0.683  0.77  0.05  0.24  0.72 
12 0.614  0.85  0.05  0.16  0.8 
13 0.390  0.85  0.11  0.19  0.74 
14 0.368  0.92  0.11  0.13  0.81 
15 0.318  0.92  0.16  0.18  0.76 
16 0.286  0.92  0.21  0.22  0.71 
17 0.231  0.92  0.26  0.27  0.66 
18 0.185  0.92  0.32  0.33  0.6 
19 0.105  0.92  0.37  0.38  0.55 
20 0.085  0.92  0.42  0.43  0.5 
21 0.064  0.92  0.47  0.48  0.45 
22 0.055  1.00  0.47  0.47  0.53 
23 0.047  1.00  0.53  0.53  0.47 
24 0.032  1.00  0.58  0.58  0.42 
25 0.026  1.00  0.63  0.63  0.37 
26 0.025  1.00  0.68  0.68  0.32 
27 0.024  1.00  0.74  0.74  0.26 
28 0.023  1.00  0.79  0.79  0.21 
29 0.021  1.00  0.84  0.84  0.16 
30 0.018  1.00  0.89  0.89  0.11 
31 0.016  1.00  0.95  0.95  0.05 
32 0.013  1.00  1.00  1.00  0 
Relationship between the predicted probability of severe breast cancer and severity of 
breast cancer is shown in Figure 3-18. From Figure 3-18, it can be seen that if 0.368 is set as 
the threshold for the prediction of severe breast cancer, two patients with moderate breast 
cancer condition are predicted to have severe breast cancer, while one patient with severe 
breast cancer condition is predicted to have moderate breast cancer.  
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The sensitivity and specificity for this test is 0.92 and 0.89, respectively. Table 3-24 
summarizes how many persons are predicted to have severe breast cancer and how many 
persons are predicted to have moderate breast cancer for patients at different stages. 
 
Figure 3-18 Prediction of existence of cancer based on the optimal cut-off probability 
 
 
Table 3-24 Prediction of severity of breast cancer for patients at different stages 
  Predicted 
  Moderate Severe 
C 11 1 
0 1 1 
I 2 0 
II  3 0 
III 1 5 
IV 0 7 
 
 3.5.2 Use of average CathB and Age used as the predictor 
In this section, average CathB and age are used as the predictors to predict if the person has 
severe breast cancer. Estimates of parameters are shown in Table 3-25. Probability of 
having breast cancer for each patient is shown in Table 3-26. 
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Table 3-25 Analysis of Maximum Likelihood Estimates 
                                                                                   Standard          Wald 
 Parameter    DF    Estimate       Error           Chi-Square    Pr > ChiSq 
 Intercept      1       -9.9959          4.1125        5.9078           0.0151 
 CathB            1         3.374E-6      1.214E-6    7.7236           0.0055 
 Age                1         0.0898           0.0568        2.4994           0.1139 
 
Table 3-26 Probability of having breast cancer for each patient 
Obs Patient Age Staging CathB level Prob 
1 B1 41 0 1353355 moderate 0.148  
2 B2 64 IV 1770087 severe 0.849  
3 B3 45 0 254411 moderate 0.006  
4 B4 59 I 442882.7 moderate 0.039  
5 B5 65 III 1611268 severe 0.782  
6 B6 77 IV 3335243 severe 1.000  
7 B6a 81 I 347228.3 moderate 0.175  
8 B7 78 IV 2626708 severe 0.997  
9 B8 75 III 2473030 severe 0.994  
10 B10 59 II 1264716 moderate 0.394  
11 B11 46 III 677698.3 severe 0.027  
12 B12 62 IV 1697287 severe 0.786  
13 B13 40 IV 2419770 severe 0.853  
14 B14 40 II 1060055 moderate 0.056  
15 B15 36 III 3481133 severe 0.993  
16 B16 53 IV 3226621 severe 0.997  
17 B17 52 III 2723205 severe 0.979  
18 B18 43 IV 2720022 severe 0.954  
19 B19 51 II 456155 moderate 0.020  
20 B20 80 III 1327514 severe 0.841  
21 C1 47 C 1220798 moderate 0.160  
22 C2 51 C 1785704 moderate 0.648  
23 C3 28 C 806983.7 moderate 0.009  
24 C4 32 C 873253.3 moderate 0.015  
25 C5 62 C 313112.3 moderate 0.033  
26 C6 48 C 1140311 moderate 0.137  
27 C7 49 C 627024.3 moderate 0.030  
28 C8 26 C 428675.7 moderate 0.002  
29 C9 42 C 720771.7 moderate 0.022  
30 C10 60 C 387576 moderate 0.036  
31 C11 26 C 420150.7 moderate 0.002  
32 C12 44 C 515214.7 moderate 0.013  
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Table 3-27 lists sensitivity and 1-specificity calculated under different cut-off probabilities 
and Figure 3-19 is the ROC curve. From Table 3-26, it is found that 0.782 is the optimal cut-
off probability to predict if the person has severe breast cancer. If the predicted probability 
of a person is above 0.782, this person is predicted to have severe breast cancer. If the 
predicted probability of a person is below 0.782, this person is predicted to have moderate 
breast cancer. The area under the ROC curve is 0.9555, indicating this test method is 
excellent. 
 
Figure 3-19 ROC curve of the model 
 
 
 
Table 3-27 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 1.000  0.08  0.00  0.92  0.08 
2 0.997  0.15  0.00  0.85  0.15 
3 0.997  0.23  0.00  0.77  0.23 
4 0.994  0.31  0.00  0.69  0.31 
5 0.993  0.38  0.00  0.62  0.38 
6 0.979  0.46  0.00  0.54  0.46 
7 0.955  0.54  0.00  0.46  0.54 
8 0.853  0.62  0.00  0.38  0.62 
9 0.849  0.69  0.00  0.31  0.69 
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10 0.841  0.77  0.00  0.23  0.77 
11 0.786  0.85  0.00  0.15  0.85 
12 0.782  0.92  0.00  0.08  0.92 
13 0.648  0.92  0.05  0.09  0.87 
14 0.394  0.92  0.11  0.13  0.81 
15 0.175  0.92  0.16  0.18  0.76 
16 0.160  0.92  0.21  0.22  0.71 
17 0.148  0.92  0.26  0.27  0.66 
18 0.137  0.92  0.32  0.33  0.6 
19 0.056  0.92  0.37  0.38  0.55 
20 0.039  0.92  0.42  0.43  0.5 
21 0.036  0.92  0.47  0.48  0.45 
22 0.033  0.92  0.53  0.53  0.39 
23 0.030  0.92  0.58  0.58  0.34 
24 0.027  1.00  0.58  0.58  0.42 
25 0.022  1.00  0.63  0.63  0.37 
26 0.020  1.00  0.68  0.68  0.32 
27 0.015  1.00  0.74  0.74  0.26 
28 0.013  1.00  0.79  0.79  0.21 
29 0.009  1.00  0.84  0.84  0.16 
30 0.006  1.00  0.89  0.89  0.11 
31 0.002  1.00  0.95  0.95  0.05 
32 0.002  1.00  1.00  1.00  0 
 
 
When the cut-off probability is set to be 0.782, the relationship between the predicted 
existence of severe breast cancer and the actual diagnosis is shown in Figure 3-20. No 
patient with moderate breast cancer condition is predicted to have severe breast cancer, 
while one patient with severe breast cancer condition is predicted to have moderate breast 
cancer. The sensitivity and specificity for this test is 0.92 and 1.00, respectively. Table 3-28 
summarizes how many persons are predicted to have severe breast cancer and how many 
persons are predicted to have moderate breast cancer for patients at different stages. 
 
Table 3-28 Prediction of severity of breast cancer for patients at different stages 
  Predicted 
  Moderate Severe 
C 12 0 
0 2 0 
I 2 0 
II  3 0 
III 1 5 
IV 0 7 
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Figure 3-20 Prediction of existence of cancer based on the optimal cut-off probability 
 
 
 3.5.3 Comparison of models in section 3.5.1 and 3.5.2 
Probabilities computed in section 3.5.1 and section 3.5.2 are presented in Table 3-29. From 
Table 3-28, it can be seen that the probabilities calculated are quite similar for patients 
whose ages are close to the average age of the group, indicating age plays a role in the 
analysis. Comparison of the predicted results is shown in Figure 3-21. Including of age 
predictor increases the area under the ROC curve and increases sensitivity and prediction. 
Table 3-29 Comparison of probabilities of having breast cancer for each patient 
between the two models in section 3.5.1 and 3.5.2 
Obs Patient Staging CathB level Prob1  Age Prob2 
1 B1 0 1353355 moderate 0.390  41 0.148  
2 B10 II 1264716 moderate 0.318  59 0.394  
3 B11 III 677698.3 severe 0.055  46 0.027  
4 B12 IV 1697287 severe 0.683  62 0.786  
5 B13 IV 2419770 severe 0.965  40 0.853  
6 B14 II 1060055 moderate 0.185  40 0.056  
7 B15 III 3481133 severe 0.999  36 0.993  
8 B16 IV 3226621 severe 0.998  53 0.997  
9 B17 III 2723205 severe 0.988  52 0.979  
10 B18 IV 2720022 severe 0.988  43 0.954  
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11 B19 II 456155 moderate 0.026  51 0.020  
12 B2 IV 1770087 severe 0.736  64 0.849  
13 B20 III 1327514 severe 0.368  80 0.841  
14 B3 0 254411 moderate 0.013  45 0.006  
15 B4 I 442882.7 moderate 0.025  59 0.039  
16 B5 III 1611268 severe 0.614  65 0.782  
17 B6 IV 3335243 severe 0.999  77 1.000  
18 B6a I 347228.3 moderate 0.018  81 0.175  
19 B7 IV 2626708 severe 0.983  78 0.997  
20 B8 III 2473030 severe 0.971  75 0.994  
21 C1 C 1220798 moderate 0.285  47 0.160  
22 C10 C 387576 moderate 0.021  60 0.036  
23 C11 C 420150.7 moderate 0.023  26 0.002  
24 C12 C 515214.7 moderate 0.032  44 0.013  
25 C2 C 1785704 moderate 0.746  51 0.648  
26 C3 C 806983.7 moderate 0.085  28 0.009  
27 C4 C 873253.3 moderate 0.105  32 0.015  
28 C5 C 313112.3 moderate 0.016  62 0.033  
29 C6 C 1140311 moderate 0.231  48 0.137  
30 C7 C 627024.3 moderate 0.047  49 0.030  
31 C8 C 428675.7 moderate 0.024  26 0.002  
32 C9 C 720771.7 moderate 0.064  42 0.022  
 
Figure 3-21 Prediction of existence of cancer based on the optimal cut-off probability 
for the models used in section 3.5.1 and 3.5.2 
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 3.6 Importance of age variable 
Table 3-30 is a summary of the importance of the age variable. For all the three datasets, 
including age as one the predictor increases the area under the ROC curve, and increases 
optimal cut-off probability. Except for the results in section 3.3 where stages 0 and I are 
deleted, including age variable also increases sensitivity and specificity. As a result, it is 
recommended that for similar research situation, age should be used as a predictor in the 
model. 
Table 3-30 Effects of age factor and deletion of stages on area under the ROC curve, 
optimal cut-off probability, sensitivity, specificity, and p-value 
Predictor Division of two  Area under  Cut-off Sensi Speci P-value 
   groups  the ROC   Prob     CathB Age 
Average CathB 
Cancer (II, III, IV) 
 No cancer (C) 
0.8854 0.58 0.81 0.92 0.0102 N/A 
 
Moderate cancer (C, 0, I) 
Severe cancer (III, IV) 
0.9423 0.421 0.92 0.87 0.0072 N/A 
 
Moderate cancer (C, 0, I, II) 
Severe cancer (III, IV) 
0.9433 0.368 0.92 0.89 0.0069 N/A 
Average 
CathB+Age 
Cancer (II, III, IV) 
 No cancer (C) 
0.9063 0.723 0.81 0.92 0.0177 0.1431 
 
Moderate cancer (C, 0, I) 
Severe cancer (III, IV) 
0.9567 0.816 0.92 1 0.0062 0.1188 
  
Moderate cancer (C, 0, I, II) 
Severe cancer (III, IV) 
0.9555 0.782 0.92 1 0.0055 0.1139 
 
 3.7 Analysis based on multicategory logistic model (complete data) 
In this section, age and average CathB are used as the predictors to predict the probabilities 
of each stage of cancer for different persons. Breast cancer of staging 0 and control group 
are combined as the control group. There are in total five responses: control, staging I, 
staging II, staging III and staging IV. Analysis of effects of different parameters is shown in 
Table 3-31. Estimates of parameters are shown in Table 3-32. Table 3-32 lists the intercepts 
and coefficients of the four equations fit for the four cancer stages, I, II, III, and IV. The 
intercept and coefficient of the equation for control group are set to be 0 by default. 
Probabilities of each stage of breast cancer for different persons are shown in Table 3-33. 
For example, the first line of Table 3-33, for the first observation, the probability that this 
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person does not have breast cancer or has a breast cancer at stage 0 is 0.727, whereas, the 
probabilities of have breast cancer at stage I, II, III, or IV is 0.000, 0.149, 0.090, and 0.034, 
respectively. The p-values of average CathB and age are 0.0771 and 0.3384, indicating 
average CathB has a marginal effect on stage of breast cancer, whereas age has little effect 
on stage of breast cancer. 
 
Table 3-31 Analysis of Effects 
Effect DF Chi-Square Pr > ChiSq 
average CathB 4 8.4291 0.0771 
Age 4 4.5348 0.3384 
Table 3-32 Coefficients and intercept of the four logistic regression equations fit for 
the four cancer stages 
Parameter Staging DF Estimate      Error 
      Standard 
Chi-square 
Wald 
Pr>ChiSq 
Intercept IV 1 -14.1369 5.4963 6.6155 0.0101 
Intercept III 1 -11.3583 4.7944 5.6126 0.0178 
Intercept II 1 -4.7017 3.2863 2.0469 0.1525 
Intercept I 1 -12.3027 8.295 2.1997 0.138 
average CathB IV 1 3.85E-06 1.43E-06 7.2307 0.0072 
average CathB III 1 2.92E-06 1.28E-06 5.2589 0.0218 
average CathB II 1 5.45E-07 1.25E-06 0.1904 0.6626 
average CathB I 1 -3.33E-06 4.46E-06 0.5602 0.4542 
Age IV 1 0.143 0.0806 3.1516 0.0759 
Age III 1 0.1295 0.0763 2.8835 0.0895 
Age II 1 0.0581 0.0625 0.8627 0.353 
Age I 1 0.2163 0.1405 2.3676 0.1239 
 
For each person, the stage of cancer is predicted to be the one with the largest probability. 
As a summary, table 3-34 lists the numbers of persons predicted to have breast cancers of 
different stages. 
Table 3-33 Probabilities of breast cancer in each stage for each patient 
Obs Age Staging CathB 
Prob at stage 0 
or no cancer 
Prob at 
stage I 
Prob at 
stage II 
Prob at 
stage III 
Prob at 
stage IV 
1 41 C 1353355 0.727 0.000 0.149 0.090 0.034 
2 64 IV 1770087 0.061 0.001 0.060 0.499 0.379 
3 45 C 254411 0.844 0.028 0.120 0.007 0.001 
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4 59 I 442882.7 0.548 0.198 0.195 0.049 0.010 
5 65 III 1611268 0.085 0.002 0.081 0.499 0.332 
6 77 IV 3335243 0.000 0.000 0.000 0.206 0.794 
7 81 I 347228.3 0.016 0.940 0.020 0.019 0.005 
8 78 IV 2626708 0.001  0.000  0.002  0.330  0.668  
9 75 III 2473030 0.001  0.000  0.004  0.370  0.625  
10 59 II 1264716 0.334  0.008  0.186  0.327  0.145  
11 46 III 677698.3 0.807  0.008  0.153  0.026  0.006  
12 62 IV 1697287 0.095  0.001  0.080  0.487  0.337  
13 40 IV 2419770 0.160  0.000  0.056  0.392  0.393  
14 40 II 1060055 0.816  0.001  0.135  0.038  0.011  
15 36 III 3481133 0.009  0.000  0.004  0.279  0.708  
16 53 IV 3226621 0.002  0.000  0.002  0.283  0.713  
17 52 III 2723205 0.014  0.000  0.011  0.381  0.594  
18 43 IV 2720022 0.045  0.000  0.022  0.392  0.541  
19 51 II 456155 0.755  0.046  0.170  0.025  0.005  
20 80 III 1327514 0.030  0.052  0.058  0.529  0.331  
21 47 C 1220798 0.657  0.001  0.178  0.120  0.043  
22 51 C 1785704 0.245  0.000  0.114  0.390  0.252  
23 28 C 806983.7 0.928  0.000  0.067  0.004  0.001  
24 32 C 873253.3 0.905  0.000  0.085  0.009  0.002  
25 62 C 313112.3 0.390  0.415  0.154  0.035  0.007  
26 48 C 1140311 0.668  0.002  0.184  0.109  0.037  
27 49 C 627024.3 0.773  0.017  0.170  0.032  0.007  
28 26 C 428675.7 0.949  0.000  0.049  0.001  0.000  
29 42 C 720771.7 0.844  0.003  0.130  0.019  0.004  
30 60 C 387576 0.498  0.268  0.182  0.043  0.009  
31 26 C 420150.7 0.949  0.000  0.049  0.001  0.000  
32 44 C 515214.7 0.844  0.009  0.131  0.013  0.002  
 
Table 3-34 Prediction of staging of breast cancer for patients at different stages of 
breast cancer 
Staging 
Predicted Stage 
C I III IV Sum 
C 10 1 1 
 
12 
I 1 1 
  
2 
II 3 
   
3 
III 1 
 
2 3 6 
IV 
  
2 5 7 
Sum 17 2 5 8 32 
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 3.8 Analysis based on CART 
The data are also analyzed by a classification tree. The aim is to predict if the person has 
severe or moderate breast cancer based on predictors of average CathB and age. The 
persons are divided into two groups using the same method as in section 3.5. Patients with 
breast cancer of stages III and IV are grouped together as severe breast cancer group. The 
others are grouped together as moderate breast cancer group. The output is shown in 
Figure 22. If the average CathB is greater than 1.296E06, the patient is predicted to have 
severe breast cancer. On the contrary, if the average CathB of the individual is smaller than 
1.296E06, the individual is predicted to have moderate breast cancer. 13 persons are 
predicted to have severe breast cancer, whereas, 1 of them actually has moderate breast 
cancer. 19 persons are predicted to have moderate breast cancer, whereas, 2 of them have 
severe breast cancer. Table 3-35 shows the predicted breast cancer condition for each 
patient.  
 
Figure 3-22 Prediction of breast cancer condition based on CART model 
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Table 3-35 Predicted breast cancer condition by tree model 
Patient Age Staging Level averCathB  predicted 
B1 41 0 moderate 1353355 Severe 
B2 64 IV severe 1770087 Severe 
B3 45 0 moderate 254411 Moderate 
B4 59 I moderate 442882.7 Moderate 
B5 65 III severe 1611268 Severe 
B6 77 IV severe 3335243 Severe 
B6a 81 I moderate 347228.3 Moderate 
B7 78 IV severe 2626708 Severe 
B8 75 III severe 2473030 Severe 
B10 59 II moderate 1264716 Moderate 
B11 46 III severe 677698.3 Moderate 
B12 62 IV severe 1697287 Severe 
B13 40 IV severe 2419770 Severe 
B14 40 II moderate 1060055 Moderate 
B15 36 III severe 3481133 Severe 
B16 53 IV severe 3226621 Severe 
B17 52 III severe 2723205 Severe 
B18 43 IV severe 2720022 Severe 
B19 51 II moderate 456155 Moderate 
B20 80 III severe 1327514 Severe 
C1 47 C moderate 1220798 Moderate 
C2 51 C moderate 1785704 Severe 
C3 28 C moderate 806983.7 Moderate 
C4 32 C moderate 873253.3 Moderate 
C5 62 C moderate 313112.3 Moderate 
C6 48 C moderate 1140311 Moderate 
C7 49 C moderate 627024.3 Moderate 
C8 26 C moderate 428675.7 Moderate 
C9 42 C moderate 720771.7 Moderate 
C10 60 C moderate 387576 Moderate 
C11 26 C moderate 420150.7 Moderate 
C12 44 C moderate 515214.7 Moderate 
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Figure 3-23 Scatter plot of enzyme pattern vs severity of breast cancer 
 
The prediction for patients in the moderate breast cancer group and in the severe breast 
cancer group is illustrated in Figure 3-23. It can be seen that two persons in the moderate 
breast cancer group are predicted to have severe breast cancer, whereas, one patient with 
severe breast cancer is predicted to have moderate breast cancer.  
The measures to assess a diagnostic test are as follows:  
(1) Sensitivity is the proportion of the patients with severe breast cancer 
diagnosis that are correctly identified by the test. 
Sensitivity =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕 𝑠𝑒𝑣𝑒𝑟𝑒 𝑏𝑟𝑒𝑎𝑠𝑡 𝑐𝑎𝑛𝑐𝑒𝑟 𝑡𝑕𝑎𝑡 𝑎𝑟𝑒 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕 𝑠𝑒𝑣𝑒𝑟𝑒 𝑏𝑟𝑒𝑎𝑠𝑡 𝑐𝑎𝑛𝑐𝑒𝑟
=
12
13
= 0.923 
(2) Specificity is the proportion of the patients with moderate breast cancer 
diagnosis that are correctly identified by the test. 
Specificity
=
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕 𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒 𝑏𝑟𝑒𝑎𝑠𝑡 𝑐𝑎𝑛𝑐𝑒𝑟 𝑡𝑕𝑎𝑡 𝑎𝑟𝑒 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑤𝑖𝑡𝑕 𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒 𝑏𝑟𝑒𝑎𝑠𝑡 𝑐𝑎𝑛𝑐𝑒𝑟
=
17
19
= 0.895 
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(3) Proportion of correct diagnoses for moderate patients is 
17
18
= 0.944 
(4) Proportion of corrected diagnoses for severe patients is 
12
14
= 0.857 
(5) Prevalence of abnormality is the proportion of severe patients among all the 
individuals in the test. 
Prevalence of abnormality
=
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑒𝑣𝑒𝑟𝑒 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠 𝑖𝑛 𝑡𝑕𝑒 𝑡𝑒𝑠𝑡
=
13
32
= 0.406 
(6) Positive predictive value (PPV) is the proportion of patients with severe test 
results who are correctly diagnosed. 
Positive predictive value
=
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 + (1 − 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦) ∗ (1 − 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒)
=
0.923 ∗ 0.406
0.923 ∗ 0.406 + (1 − 0.895) ∗ (1 − 0.406)
= 0.857 
(7) Negative predictive value (NPV) is the proportion of patients with moderate 
test results who are correctly diagnosed. 
Negative predictive value
=
𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒
(1 − 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦) ∗ 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 + 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 ∗ (1 − 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒)
=
0.895 ∗ 0.406
(1 − 0.923) ∗ 0.406 + 0.895 ∗ (1 − 0.406)
= 0.646 
(8) Likelihood ratio is the ratio of the probability of getting a severe result if the 
patient truly had the severe breast cancer and the probability of getting severe results if 
the individual was healthy. 
Likelihood ratio =
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
(1 − 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦)
=
0.923
1 − 0.895
= 8.79 
It needs to note that the number of wrongly predicted patients is the same as the number 
obtained by the logistic regression model when average CathB is used as the predictor 
(model in section 3.5.1) and this grouping is used. 
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Chapter 4 - Assessing Diagnostic Test for Breast Cancer (data 
MMP1) 
 4.1 Overview of the data 
Another type of nanoparticle is used to detect breast cancer by examining the enzyme 
pattern in the blood of a patient. The nanoparticles are coated with matrix 
metalloproteinase-1, which is a type of proteases to interact with the enzyme in the blood 
samples. Information on enzyme activity, patients’ ages and stages of cancer were recorded. 
Relationships between average MMP, staging of cancer, and age of patient are shown in 
Figure 4-1and Figure 4-2. From these boxplots, it can be seen that the patients with cancer 
stages of I, II, III, and IV have higher average MMP than the persons in the control group, 
which includes healthy persons, and patients with a cancer stage of 0. But the differences 
among average MMP of patients with breast cancer of stage of I, II, III, and IV are not 
remarkable. Age of patient does not show a significant relationship with average MMP. As 
seen in chapter 3, age of patient does seem to have a relationship with staging of breast 
cancer. Patients with breast cancer of stage I, II, III, and IV are older than the persons 
without breast cancer or with breast cancer of stage 0. 
 
Figure 4-1 Boxplot of average MMP vs staging of cancer 
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Figure 4-2 Scatterplot of average MMP vs age of patient 
 
 
 4.2 Comparison of three measurements  
The enzyme pattern of each person was tested three times on different days. Figure 4-3 
shows the results of the three measurements. It can be seen that the experimental error is 
very small. In addition, a logistic regression model is also used to predict the probability of 
having breast cancer for each person by using the individual enzyme pattern instead of the 
average enzyme pattern over the three measurements. If the person has breast cancer of 
stage I, II, III and IV, this person belongs to the “having breast cancer” group. If the person 
has no breast cancer or if he has breast cancer of stage 0, the person belongs to the “having 
no breast cancer” group. The probability of having breast cancer for each patient is shown 
in Figure 4-4, which shows that there is no noticeable difference between the three 
probabilities for all the persons. As a result, in this chapter, the models are built based on 
the average value of these three measurements.  
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Figure 4-3 Scatter plot of the three enzyme patterns of different patients 
 
 
Figure 4-4 Probability of having breast cancer for each patient predicted by logistic 
regression using individual enzyme pattern as the predictor 
 
 
 4.3 Analysis based on logistic regression with binary response 
 4.3.1 Use of average MMP as the predictor 
A logistic regression model is used to predict the probability of having breast cancer for 
each person. Patients with breast cancer of staging I, II, III, and IV are grouped together as 
having breast cancer, whereas the persons without breast cancer or with breast cancer of 
stage 0 are grouped together as having no breast cancer. When average MMP is used as the 
predictor, the estimates of parameters are shown in Table 4-1. The probability of having 
breast cancer for each patient is shown in Table 4-2. 
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Table 4-1 Analysis of Maximum Likelihood Estimates 
Standard          Wald 
                                       Parameter    DF    Estimate       Error          Chi-Square    Pr > ChiSq 
Intercept       1     -6.5605           2.2377        8.5959           0.0034 
MMP               1      11.5520         3.6899        9.8014           0.0017 
  
Table 4-2 Probability of having breast cancer for each patient 
Obs Patient Age Staging MMP Cancer Prob 
1 B1 41 0 0.36336 No 0.086  
2 B2 64 IV 0.37156 Yes 0.094  
3 B3 45 0 0.35821 No 0.081  
4 B4 59 I 0.75493 Yes 0.897  
5 B5 65 III 0.76096 Yes 0.903  
6 B6 77 IV 0.77706 Yes 0.918  
7 B6a 81 I 0.76101 Yes 0.903  
8 B7 78 IV 0.8197 Yes 0.948  
9 B8 75 III 0.66058 Yes 0.745  
10 B10 59 II 0.64032 Yes 0.698  
11 B11 46 III 0.60873 Yes 0.616  
12 B12 62 IV 0.62555 Yes 0.661  
13 B13 40 IV 0.58121 Yes 0.538  
14 B14 40 II 0.79096 Yes 0.929  
15 B15 36 III 0.95323 Yes 0.988  
16 B16 53 IV 1.2534 Yes 1.000  
17 B17 52 III 0.98838 Yes 0.992  
18 B18 43 IV 0.77332 Yes 0.915  
19 B19 51 II 0.70182 Yes 0.824  
20 B20 80 III 0.80806 Yes 0.941  
21 C1 47 C 0.45603 No 0.215  
22 C2 51 C 0.32572 No 0.057  
23 C3 28 C 0.51654 No 0.356  
24 C4 32 C 0.61482 No 0.632  
25 C5 62 C 0.64015 No 0.697  
26 C6 48 C 0.76616 No 0.908  
27 C7 49 C 0.33458 No 0.063  
28 C8 26 C 0.34843 No 0.073  
29 C9 42 C 0.30096 No 0.044  
30 C10 60 C 0.29954 No 0.043  
31 C11 26 C 0.36683 No 0.089  
32 C12 44 C 0.41336 No 0.144  
 
 
The optimal cut-off probability to predict if the person has breast cancer is found by a ROC 
curve. Table 4-3 lists sensitivity and 1-specificity calculated under different cut-off 
probabilities and Figure 4-5 is the ROC curve. The optimal cut-off probability is the one 
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which has the smallest distance to the point (0,1) and at the same time has the largest 
vertical distance to the line of equality. Based on these criteria, the probability of 0.538 is 
the optimal cut-off probability to predict if the person has breast cancer. If the predicted 
probability of a person is above 0.538, this person is predicted to have breast cancer. If the 
predicted probability of a person is below 0.538, this person is predicted to have no breast 
cancer. The area under the ROC curve is 0.9206, indicating this test method is excellent. 
 
Table 4-3 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 1.000  0.06  0.00  0.94  0.06 
2 0.992  0.11  0.00  0.89  0.11 
3 0.988  0.17  0.00  0.83  0.17 
4 0.948  0.22  0.00  0.78  0.22 
5 0.941  0.28  0.00  0.72  0.28 
6 0.929  0.33  0.00  0.67  0.33 
7 0.918  0.39  0.00  0.61  0.39 
8 0.915  0.44  0.00  0.56  0.44 
9 0.908  0.44  0.07  0.56  0.37 
10 0.903  0.50  0.07  0.51  0.43 
11 0.903  0.56  0.07  0.45  0.49 
12 0.897  0.61  0.07  0.40  0.54 
13 0.824  0.67  0.07  0.34  0.6 
14 0.745  0.72  0.07  0.29  0.65 
15 0.698  0.78  0.07  0.23  0.71 
16 0.697  0.78  0.14  0.26  0.64 
17 0.661  0.83  0.14  0.22  0.69 
18 0.632  0.83  0.21  0.27  0.62 
19 0.616  0.89  0.21  0.24  0.68 
20 0.538  0.94  0.21  0.22  0.73 
21 0.356  0.94  0.29  0.29  0.65 
22 0.215  0.94  0.36  0.36  0.58 
23 0.144  0.94  0.43  0.43  0.51 
24 0.094  1.00  0.43  0.43  0.57 
25 0.089  1.00  0.50  0.50  0.5 
26 0.086  1.00  0.57  0.57  0.43 
27 0.081  1.00  0.64  0.64  0.36 
28 0.073  1.00  0.71  0.71  0.29 
29 0.063  1.00  0.79  0.79  0.21 
30 0.057  1.00  0.86  0.86  0.14 
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31 0.044  1.00  0.93  0.93  0.07 
32 0.043  1.00  1.00  1.00  0 
 
Figure 4-5 ROC curve of the model 
 
 
When the cut-off probability is set to be 0.538, the relationship between the predicted 
existence of breast cancer and the actual diagnosis is shown in Figure 4-6. Three persons in 
the control group are predicted to have cancer, whereas, one person in the case group is 
predicted to have no breast cancer. The sensitivity and specificity for this test is 0.94 and 
0.79, respectively. Table 4-4 summarizes how many persons are predicted to have breast 
cancer and how many persons are predicted to have no breast cancer for patients at 
different stages of breast cancer. 
 
Table 4-4 Prediction of existence of breast cancer for patients at different stages 
  Predicted 
  No Yes 
C 9 3 
0 2 0 
I 0 2 
II 0 3 
III 0 6 
IV 1 6 
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Figure 4-6 Prediction of existence of cancer based on the optimal cut-off probability 
 
 
 4.3.2 Use of average MMP and age as the predictors 
In this section, average MMP and age are used as the predictors to predict if the person has 
breast cancer. Estimates of parameters are shown in Table 4-5. The probability of having 
breast cancer for each patient is shown in Table 4-6. 
 
Table 4-5 Analysis of Maximum Likelihood Estimates 
Standard         Wald 
        Parameter    DF  Estimate     Error      Chi-Square    Pr > ChiSq 
         Intercept     1    -10.5871      3.7763        7.8599        0.0051 
         MMP             1     10.2277       3.6114        8.0207        0.0046 
         Age                1      0.0970        0.0565        2.9495        0.0859 
 
Table 4-6 Probability of having breast cancer for each patient  
Obs Patient Age Staging MMP Cancer Prob 
1 B1 41 0 0.36336 No 0.052  
2 B2 64 IV 0.37156 Yes 0.359  
3 B3 45 0 0.35821 No 0.072  
4 B4 59 I 0.75493 Yes 0.946  
5 B5 65 III 0.76096 Yes 0.971  
6 B6 77 IV 0.77706 Yes 0.992  
7 B6a 81 I 0.76101 Yes 0.994  
8 B7 78 IV 0.8197 Yes 0.995  
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9 B8 75 III 0.66058 Yes 0.969  
10 B10 59 II 0.64032 Yes 0.844  
11 B11 46 III 0.60873 Yes 0.525  
12 B12 62 IV 0.62555 Yes 0.861  
13 B13 40 IV 0.58121 Yes 0.318  
14 B14 40 II 0.79096 Yes 0.799  
15 B15 36 III 0.95323 Yes 0.934  
16 B16 53 IV 1.2534 Yes 0.999  
17 B17 52 III 0.98838 Yes 0.990  
18 B18 43 IV 0.77332 Yes 0.817  
19 B19 51 II 0.70182 Yes 0.823  
20 B20 80 III 0.80806 Yes 0.996  
21 C1 47 C 0.45603 No 0.204  
22 C2 51 C 0.32572 No 0.090  
23 C3 28 C 0.51654 No 0.070  
24 C4 32 C 0.61482 No 0.232  
25 C5 62 C 0.64015 No 0.878  
26 C6 48 C 0.76616 No 0.870  
27 C7 49 C 0.33458 No 0.082  
28 C8 26 C 0.34843 No 0.011  
29 C9 42 C 0.30096 No 0.031  
30 C10 60 C 0.29954 No 0.154  
31 C11 26 C 0.36683 No 0.013  
32 C12 44 C 0.41336 No 0.110  
 
Table 4-7 lists sensitivity and 1-specificity calculated under different cut-off probabilities 
and Figure 4-7 is the ROC curve. From Table 4-7, it is found that 0.318 is the optimal cut-off 
probability to predict if the person has breast cancer. If the predicted probability of a 
person is above 0318, this person is predicted to have breast cancer. If the predicted 
probability of a person is below 0.3188, this person is predicted to have no breast cancer. 
The area under the ROC curve is 0.9365, indicating this test method is excellent. 
 
Table 4-7 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 0.999  0.06  0.00  0.94  0.06 
2 0.996  0.11  0.00  0.89  0.11 
3 0.995  0.17  0.00  0.83  0.17 
4 0.994  0.22  0.00  0.78  0.22 
5 0.992  0.28  0.00  0.72  0.28 
6 0.990  0.33  0.00  0.67  0.33 
7 0.971  0.39  0.00  0.61  0.39 
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8 0.969  0.44  0.00  0.56  0.44 
9 0.946  0.50  0.00  0.50  0.5 
10 0.934  0.56  0.00  0.44  0.56 
11 0.878  0.56  0.07  0.45  0.49 
12 0.870  0.56  0.14  0.47  0.42 
13 0.861  0.61  0.14  0.41  0.47 
14 0.843  0.67  0.14  0.36  0.53 
15 0.823  0.72  0.14  0.31  0.58 
16 0.816  0.78  0.14  0.26  0.64 
17 0.799  0.83  0.14  0.22  0.69 
18 0.525  0.89  0.14  0.18  0.75 
19 0.359  0.94  0.14  0.15  0.8 
20 0.318  1.00  0.14  0.14  0.86 
21 0.232  1.00  0.21  0.21  0.79 
22 0.203  1.00  0.29  0.29  0.71 
23 0.154  1.00  0.36  0.36  0.64 
24 0.110  1.00  0.43  0.43  0.57 
25 0.090  1.00  0.50  0.50  0.5 
26 0.082  1.00  0.57  0.57  0.43 
27 0.072  1.00  0.64  0.64  0.36 
28 0.070  1.00  0.71  0.71  0.29 
29 0.052  1.00  0.79  0.79  0.21 
30 0.031  1.00  0.86  0.86  0.14 
31 0.013  1.00  0.93  0.93  0.07 
32 0.011  1.00  1.00  1.00  0 
 
Figure 4-7 ROC curve of the model 
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When the cut-off probability is set to be 0.318, the relationship between the predicted 
existence of breast cancer and the actual diagnosis is shown in Figure 4-8. One person in 
the control group is predicted to have breast cancer, whereas, no person in the case group is 
predicted to have no breast cancer. The sensitivity and specificity for this test is 1.00 and 
0.86, respectively. Table 4-8 summarizes how many persons are predicted to have breast 
cancer and how many persons are predicted to have no breast cancer for patients at 
different stages. 
 
Figure 4-8 Prediction of existence of cancer based on the optimal cut-off probability 
 
 
Table 4-8 Prediction of existence of breast cancer for patients at different stages 
  Predicted 
  No Yes 
C 10 2 
0 2 0 
I 0 2 
II 0 3 
III 0 6 
IV 0 7 
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 4.3.3 Comparison of models in section 4.2.1 and 4.2.2 
Table 4-9 compares the probabilities calculated by the models in section 4.2.1 (average 
MMP is used as the predictor) and section 4.2.2 (average MMP and age are used as the 
predictors). The difference between the probabilities is relatively large when the age of the 
patient is far from the average age of the patients involved in the test. When the age of the 
patient is close to the average age, the difference is relatively small, indicating age plays a 
role in the analysis. 
 
Table 4-9 Comparison of probabilities of having breast cancer for each patient 
between the two models in section 4.2.1 and 4.2.2 
Obs Patient Age Staging MMP Cancer Prob1 Prob2 
1 B1 41 0 0.36336 No 0.086 0.052 
2 B2 64 IV 0.37156 Yes 0.094 0.359 
3 B3 45 0 0.35821 No 0.081 0.072 
4 B4 59 I 0.75493 Yes 0.897 0.946 
5 B5 65 III 0.76096 Yes 0.903 0.971 
6 B6 77 IV 0.77706 Yes 0.918 0.992 
7 B6a 81 I 0.76101 Yes 0.903 0.994 
8 B7 78 IV 0.8197 Yes 0.948 0.995 
9 B8 75 III 0.66058 Yes 0.745 0.969 
10 B10 59 II 0.64032 Yes 0.698 0.844 
11 B11 46 III 0.60873 Yes 0.616 0.525 
12 B12 62 IV 0.62555 Yes 0.661 0.861 
13 B13 40 IV 0.58121 Yes 0.538 0.318 
14 B14 40 II 0.79096 Yes 0.929 0.799 
15 B15 36 III 0.95323 Yes 0.988 0.934 
16 B16 53 IV 1.2534 Yes 1 0.999 
17 B17 52 III 0.98838 Yes 0.992 0.99 
18 B18 43 IV 0.77332 Yes 0.915 0.817 
19 B19 51 II 0.70182 Yes 0.824 0.823 
20 B20 80 III 0.80806 Yes 0.941 0.996 
21 C1 47 C 0.45603 No 0.215 0.204 
22 C2 51 C 0.32572 No 0.057 0.09 
23 C3 28 C 0.51654 No 0.356 0.07 
24 C4 32 C 0.61482 No 0.632 0.232 
25 C5 62 C 0.64015 No 0.697 0.878 
26 C6 48 C 0.76616 No 0.908 0.87 
27 C7 49 C 0.33458 No 0.063 0.082 
28 C8 26 C 0.34843 No 0.073 0.011 
29 C9 42 C 0.30096 No 0.044 0.031 
30 C10 60 C 0.29954 No 0.043 0.154 
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31 C11 26 C 0.36683 No 0.089 0.013 
32 C12 44 C 0.41336 No 0.144 0.11 
 
Table 4-10 summarizes the differences of the two models in the diagnostic test of breast 
cancer. Including age as the predictor increases the area under the ROC curve, decreases the 
cut-off probability, and increases sensitivity and specificity of the test. The p-value for the 
predictor, average MMP, is decreased. The p-value for the predictor age is 0.0859, indicating 
that age has a marginal influence on the prediction. Comparison of predicted accuracy 
between the two models is shown in Figure 4-9.  
 
Figure 4-9 Prediction of existence of cancer based on the optimal cut-off probability 
for the models used in section 4.2.1 and 4.2.2 
 
 
Table 4-10 Comparison of models in section 4.2.1 and 4.2.2 
Predictor Area under  Threshold Sensi Speci P-value 
  the ROC curve        MMP Age 
Average MMP 0.9206 0.538 0.94 0.79 0.0017 N/A 
Average 
MMP+Age 
0.9365 0.318 1 0.86 0.0046 0.0859 
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 4.4 Analysis based on multicategory logistic model 
In this section, average MMP and age are used as predictors to predict the probabilities of 
each stage of cancer for different persons. Analysis of effects of different parameters is 
shown in Table 4-11. Estimates of parameters are shown in Table 4-12. Table 4-12 lists the 
intercepts and coefficients of the four equations fit for the four cancer stages, I, II, III, and IV. 
The intercept and coefficient of the equation for the control group (including the healthy 
persons and the patients with breast cancer of stage 0) are set to be 0 by default. 
Probabilities of each stage of breast cancer for different persons are calculated and shown 
in Table 4-13. For example, the first line of Table 4-13 indicates the first patient has a breast 
cancer at stage 0. Based on the diagnostic test, the probability that he or she is at stage 0 or 
has no cancer is 0.946. The probability that he or she is in stage I, II, III, or IV is 0.001, 0.026, 
0.009, and 0.019, respectively. The p-values of average MMP and age are 0.0858 and 0.3389, 
indicating average MMP has a marginal effect on stage of breast cancer, whereas age has 
little effect on stage of breast cancer. 
 
Table 4-11 Analysis of Effects 
Wald Effect DF Chi-Square Pr> ChiSq 
average MMP 4 8.1626 0.0858 
Age 4 4.531 0.3389 
                
Table 4-12 Intercepts and coefficients of the logistic regression equations fit for the 
four cancer stages 
Standard Wald 
DF Estimate Error Chi-Square Pr > ChiSq 
Parameter Staging 
Intercept IV 1 -12.1065 4.4202 7.5017 0.0062 
Intercept III 1 -13.4324 4.7881 7.8701 0.005 
Intercept II 1 -9.1344 4.3973 4.3151 0.0378 
Intercept I 1 -17.8201 7.3013 5.957 0.0147 
average MMP IV 1 10.1164 4.0257 6.3148 0.012 
average MMP III 1 11.6952 4.3402 7.2609 0.007 
average MMP II 1 8.9862 4.3099 4.3472 0.0371 
average MMP I 1 10.8368 6.4113 2.857 0.091 
Age IV 1 0.1101 0.0632 3.0387 0.0813 
Age III 1 0.1094 0.0653 2.807 0.0939 
Age II 1 0.0552 0.0672 0.6757 0.4111 
Age I 1 0.1704 0.0875 3.7937 0.0514 
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Table 4-13 Probabilities of breast cancer in each stage for each patient 
Obs Age Staging 
average 
MMP 
Prob at 
stage I  
Prob at 
stage II 
Prob at 
stage III 
Prob at 
stage IV 
Prob at stage 
0 or no cnacer 
1 41 0 0.36336 0.001  0.026  0.009  0.019  0.946  
2 64 IV 0.37156 0.036  0.067  0.080  0.175  0.643  
3 45 0 0.35821 0.002  0.030  0.012  0.027  0.929  
4 59 I 0.75493 0.080  0.131  0.336  0.401  0.053  
5 65 III 0.76096 0.118  0.096  0.347  0.412  0.026  
6 77 IV 0.77706 0.232  0.046  0.331  0.386  0.006  
7 81 I 0.76101 0.280  0.036  0.309  0.371  0.004  
8 78 IV 0.8197 0.244  0.040  0.341  0.372  0.003  
9 75 III 0.66058 0.203  0.062  0.296  0.414  0.024  
10 59 II 0.64032 0.069  0.139  0.262  0.374  0.157  
11 46 III 0.60873 0.017  0.158  0.136  0.202  0.488  
12 62 IV 0.62555 0.085  0.125  0.266  0.389  0.136  
13 40 IV 0.58121 0.006  0.125  0.072  0.111  0.686  
14 40 II 0.79096 0.018  0.247  0.250  0.278  0.206  
15 36 III 0.95323 0.017  0.274  0.346  0.297  0.066  
16 53 IV 1.2534 0.060  0.078  0.559  0.302  0.001  
17 52 III 0.98838 0.056  0.133  0.440  0.361  0.010  
18 43 IV 0.77332 0.023  0.229  0.260  0.298  0.190  
19 51 II 0.70182 0.040  0.181  0.261  0.336  0.183  
20 80 III 0.80806 0.268  0.035  0.328  0.365  0.003  
21 47 C 0.45603 0.006  0.070  0.042  0.079  0.803  
22 51 C 0.32572 0.003  0.031  0.016  0.037  0.913  
23 28 C 0.51654 0.001  0.048  0.012  0.021  0.919  
24 32 C 0.61482 0.003  0.120  0.049  0.071  0.757  
25 62 C 0.64015 0.087  0.124  0.275  0.394  0.119  
26 48 C 0.76616 0.035  0.200  0.292  0.339  0.134  
27 49 C 0.33458 0.003  0.030  0.014  0.033  0.920  
28 26 C 0.34843 0.000  0.010  0.001  0.003  0.985  
29 42 C 0.30096 0.001  0.016  0.005  0.011  0.967  
30 60 C 0.29954 0.011  0.037  0.029  0.072  0.851  
31 26 C 0.36683 0.000  0.012  0.002  0.004  0.982  
32 44 C 0.41336 0.003  0.045  0.020  0.041  0.891  
 
For each person, the stage of cancer is predicted to be the one with the largest probability. 
As a summary, table 4-14 lists the numbers of persons predicted to be breast cancers of 
different stages. 
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Table 4-14 Prediction of staging of breast cancer for patients in different staging’s of 
breast cancer 
Staging C III IV Sum 
C 10 
 
2 12 
0 2   2 
I 
  
2 2 
II 
  
3 3 
III 1 3 2 6 
IV 2 2 3 7 
Sum 15 5 12 32 
 
 4.5 Analysis based on CART 
The data are also analyzed by classification tree. These patients are divided into two groups 
based on the method used in section 4.3. If the patient has no breast cancer or has breast 
cancer at stage 0, he is in the no breast cancer group. If the patient has breast cancer at 
stage I, II, III or IV, he is in the breast cancer group. The output is shown in Figure 4-10. 12 
persons have average MMP below 0.5489 and are predicted to have no breast cancer. Out of 
them, 1 person has breast cancer. 20 persons are predicted to have breast cancer. Out of 
them, 3 persons have no breast cancer. If the average MMP is greater than 0.5489, the 
patient is predicted to have breast cancer. On the contrary, if the average MMP of the 
individual is smaller than 0.5489, the individual is predicted to have no breast cancer. The 
prediction for each patient is in Table 4-16.   
 
Table 4-15 Predicted breast cancer condition by tree model 
Patient Age Staging MMP11 MMP12 MMP13 
Average 
MMP 
Cancer 
B1 41 0 0.352169 0.377403 0.360494 0.3633552 No 
B2 64 IV 0.353283 0.377405 0.384004 0.37156407 No 
B3 45 0 0.357591 0.34873 0.3683 0.35820721 No 
B4 59 I 0.741549 0.75993 0.763322 0.75493378 Yes 
B5 65 III 0.743864 0.774038 0.764992 0.76096495 Yes 
B6 77 IV 0.774821 0.782392 0.773965 0.77705943 Yes 
B6a 81 I 0.760201 0.773043 0.749784 0.7610094 Yes 
B7 78 IV 0.827511 0.80484 0.826743 0.81969806 Yes 
B8 75 III 0.668552 0.653095 0.660093 0.66057994 Yes 
B10 59 II 0.644745 0.643923 0.632294 0.6403208 Yes 
B11 46 III 0.59722 0.608893 0.620085 0.6087327 Yes 
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B12 62 IV 0.62226 0.645563 0.608827 0.62555011 Yes 
B13 40 IV 0.56818 0.584877 0.590558 0.58120536 Yes 
B14 40 II 0.784446 0.799234 0.789203 0.79096106 Yes 
B15 36 III 0.935575 0.958493 0.965632 0.95323343 Yes 
B16 53 IV 1.212854 1.269944 1.277404 1.25340073 Yes 
B17 52 III 0.972538 1.003827 0.988784 0.98838307 Yes 
B18 43 IV 0.757089 0.776089 0.786774 0.77331739 Yes 
B19 51 II 0.688673 0.703384 0.713394 0.7018173 Yes 
B20 80 III 0.796674 0.809744 0.817749 0.80805586 Yes 
C1 47 C 0.43033 0.459904 0.477849 0.456028 No 
C2 51 C 0.308407 0.328867 0.339895 0.32572294 No 
C3 28 C 0.514881 0.504738 0.529989 0.51653638 No 
C4 32 C 0.611661 0.608947 0.623849 0.61481918 Yes 
C5 62 C 0.624123 0.650948 0.645373 0.64014824 Yes 
C6 48 C 0.768959 0.756474 0.773044 0.76615914 Yes 
C7 49 C 0.307784 0.357486 0.338473 0.33458102 No 
C8 26 C 0.355648 0.300899 0.388749 0.34843235 No 
C9 42 C 0.297403 0.30499 0.300494 0.30096246 No 
C10 60 C 0.288947 0.309804 0.299877 0.29954283 No 
C11 26 C 0.355894 0.377849 0.36674 0.3668279 No 
C12 44 C 0.403832 0.413395 0.422849 0.41335884 No 
 
Figure 4-10 Prediction of breast cancer condition based on CART model 
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The prediction for patients with breast cancer and without breast cancer is illustrated in 
Figure 4-11. It can be seen that one person with breast cancer is predicted to have no breast 
cancer, whereas, three patients without breast cancer are predicted to have breast cancer. 
 
Figure 4-11 Scatter plot of enzyme pattern vs existence of breast cancer 
 
It needs to be noted that the number of wrongly predicted patients is the same as the 
number of wrongly predicted patients obtained by the logistic regression model when 
average MMP is used as the predictor and this grouping is used (model in section 3.4.1). 
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Chapter 5 - Assessing Diagnostic Test for Lung Cancer (data 
MMP1) 
 5.1 Overview of the data 
The nanoparticles used in Chapter 4 are also used to detect lung cancer by examining the 
enzyme pattern in the blood of a patient. Information on enzyme activity, patients’ ages and 
stages of cancer were recorded. Relationships between average MMP, stage of cancer, and 
age of patient are shown in Figure 5-1, Figure 5-2, and Figure 5-3. From these boxplots, it 
can be seen that the patients with lung cancer of stages I, II, and III have higher average 
MMP than the persons in the control group. But the differences among average MMP of 
patients with lung cancer of stage I, II, and III is not remarkable. Age of patient does not 
show a significant relationship with average MMP or stage of lung cancer. 
 
Figure 5-1 Boxplot of average MMP vs staging of cancer 
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Figure 5-2 Scatterplot of average MMP vs age of patient 
 
 
Figure 5-3 Boxplot of age of patient vs staging of cancer 
 
 5.2 Comparison of three measurements  
The enzyme pattern of each person was tested three times on the different days. Figure 5-4 
shows the results of the three measurements. It can be seen that the experimental error is 
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having lung cancer for each person by using the individual enzyme pattern instead of the 
average enzyme pattern of the three measurements. If the person has lung cancer of stage I, 
II and III, this person belongs to the “having lung cancer” group. If the person has no lung 
cancer, the person belongs to the “having no lung cancer” group. The probability of having 
lung cancer for each patient is shown in Figure 5-5, which shows that for most the persons, 
there is no noticeable difference between the three probabilities, but three indicate some 
wide variability in Figure 5.5. As a result, in this chapter, the models are built based on the 
average value of these three measurements. 
 
Figure 5-4 Scatter plot of the three enzyme patterns of different patients 
 
Figure 5-5 Probability of having breast cancer for each patient predicted by logistic 
regression using individual enzyme pattern as the predictor 
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 5.3 Analysis based on logistic regression with binary response  
 5.3.1 Use of average MMP as the predictor 
A logistic regression model is used to predict the probability of having lung cancer for each 
person. Patients with lung cancer of staging I, II, and III are grouped together as having lung 
cancer, whereas the persons without lung cancer are grouped together as having no lung 
cancer. When average MMP is used as the predictor, the estimates of parameters are shown 
in Table 5-1. Probability of having lung cancer for each patient is shown in Table 5-2. 
 
Table 5-1 Analysis of Maximum Likelihood Estimates 
                                                                                                              Standard          Wald 
        Parameter            DF    Estimate      Error            Chi-Square    Pr > ChiSq 
         Intercept              1       -18.9824     12.3881        2.3480           0.1254 
         average MMP      1        27.2166     17.2605        2.4864            0.1148 
 
Table 5-2 Probability of having lung cancer for each patient  
Obs Patient Staging Average MMP Cancer Prob 
1 C1 C 0.45603 No 0.001  
2 C2 C 0.32572 No 0.000  
3 C3 C 0.51654 No 0.007  
4 C4 C 0.61482 No 0.095  
5 C5 C 0.64015 No 0.174  
6 C6 C 0.76616 No 0.866  
7 C7 C 0.33458 No 0.000  
8 C8 C 0.34843 No 0.000  
9 C9 C 0.30096 No 0.000  
10 C10 C 0.29954 No 0.000  
11 C11 C 0.36683 No 0.000  
12 C12 C 0.41336 No 0.000  
13 L1 II 1.01316 Yes 1.000  
14 L2 III 1.04613 Yes 1.000  
15 L3 II 1.00416 Yes 1.000  
16 L4 III 1.03366 Yes 1.000  
17 L5 II 0.77618 Yes 0.895  
18 L6 III 1.07635 Yes 1.000  
19 L7 I 1.04785 Yes 1.000  
20 L8 II 0.97629 Yes 0.999  
21 L9 III 0.80185 Yes 0.945  
22 L10 II 0.72741 Yes 0.693  
23 L11 III 0.72932 Yes 0.704  
24 L12 II 0.71529 Yes 0.619  
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The optimal cut-off probability to predict if the person has lung cancer is found by a ROC 
curve. Table 5-3 lists sensitivity and 1-specificity calculated under different cut-off 
probabilities and Figure 5-6 is the ROC curve. The optimal point is the one which has the 
smallest distance to the point (0, 1) and at the same time has the largest vertical distance to 
the line of equality. Based on these criteria, the probability of 0.619 is the optimal cut-off 
probability to predict if the person has lung cancer or not. If the predicted probability of a 
person is above 0619, this person is predicted to have lung cancer. If the predicted 
probability of a person is below 0.619, this person is predicted to have no lung cancer. The 
area under the ROC curve is 0.9792, indicating this test method is excellent. 
 
Figure 5-6 ROC curve of the model 
 
 
Table 5-3 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 1.000  0.08  0.00  0.92  0.08 
2 1.000  0.17  0.00  0.83  0.17 
3 1.000  0.25  0.00  0.75  0.25 
4 1.000  0.33  0.00  0.67  0.33 
5 1.000  0.42  0.00  0.58  0.42 
6 1.000  0.50  0.00  0.50  0.5 
7 0.999  0.58  0.00  0.42  0.58 
73 
 
8 0.945  0.67  0.00  0.33  0.67 
9 0.895  0.75  0.00  0.25  0.75 
10 0.866  0.75  0.08  0.26  0.67 
11 0.704  0.83  0.08  0.19  0.75 
12 0.693  0.92  0.08  0.12  0.84 
13 0.619  1.00  0.08  0.08  0.92 
14 0.174  1.00  0.17  0.17  0.83 
15 0.095  1.00  0.25  0.25  0.75 
16 0.007  1.00  0.33  0.33  0.67 
17 0.001  1.00  0.42  0.42  0.58 
18 0.000  1.00  0.50  0.50  0.5 
19 0.000  1.00  0.58  0.58  0.42 
20 0.000  1.00  0.67  0.67  0.33 
21 0.000  1.00  0.75  0.75  0.25 
22 0.000  1.00  0.83  0.83  0.17 
23 0.000  1.00  0.92  0.92  0.08 
24 0.000  1.00  1.00  1.00  0 
 
When the cut-off probability is set to be 0.619, the relationship between the predicted 
existence of lung cancer and the actual diagnosis is shown in Figure 5-7. It can be seen that 
no patient with lung cancer is predicted to have lung cancer, whereas, one person without 
lung cancer is predicted to have lung cancer. The sensitivity and specificity for this test is 
1.00 and 0.92, respectively. Table 5-4 summarizes how many persons are predicted to have 
lung cancer and how many persons are predicted to have no lung cancer for patients at 
different stages. 
 
Figure 5-7 Prediction of existence of cancer based on the optimal cut-off probability 
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Table 5-4Prediction of existence of lung cancer for patients at different stages 
  Predicted 
  No Yes 
C 11 1 
I 0 1 
II 0 6 
III 0 5 
 
 5.3.2 Use of average MMP and Age as the predictor 
In this section, average MMP and age are used as the predictors to predict if the person has 
lung cancer. Estimates of parameters are shown in Table 5-5. Probability of having lung 
cancer for each patient is shown in Table 5-6. 
 
Table 5-5 Analysis of Maximum Likelihood Estimates 
        Parameter           DF    Estimate       Error    Chi-Square    Pr > ChiSq 
        Intercept             1    -17.6394     12.0810        2.1319        0.1443 
        average MMP     1     27.7137     17.0313        2.6478        0.1037 
         Age                       1     -0.0364       0.1180          0.0954        0.7574 
 
Table 5-6 Probability of having lung cancer for each patient 
Obs Patient Age Staging average MMP Cancer Prob 
1 C1 47 C 0.45603 No 0.001  
2 C2 51 C 0.32572 No 0.000  
3 C3 28 C 0.51654 No 0.013  
4 C4 32 C 0.61482 No 0.146  
5 C5 62 C 0.64015 No 0.104  
6 C6 48 C 0.76616 No 0.864  
7 C7 49 C 0.33458 No 0.000  
8 C8 26 C 0.34843 No 0.000  
9 C9 42 C 0.30096 No 0.000  
10 C10 60 C 0.29954 No 0.000  
11 C11 26 C 0.36683 No 0.000  
12 C12 44 C 0.41336 No 0.000  
13 L1 27 II 1.01316 Yes 1.000  
14 L2 44 III 1.04613 Yes 1.000  
15 L3 63 II 1.00416 Yes 1.000  
16 L4 54 III 1.03366 Yes 1.000  
17 L5 37 II 0.77618 Yes 0.926  
18 L6 46 III 1.07635 Yes 1.000  
19 L7 51 I 1.04785 Yes 1.000  
20 L8 38 II 0.97629 Yes 1.000  
21 L9 55 III 0.80185 Yes 0.930  
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22 L10 49 II 0.72741 Yes 0.676  
23 L11 40 III 0.72932 Yes 0.753  
24 L12 50 II 0.71529 Yes 0.590  
 
Table 5-7 lists sensitivity and 1-specificity calculated under different cut-off probabilities 
and Figure 5-8 is the ROC curve. From Table 5-7, it is found that 0.589 is the optimal cut-off 
probability to predict if the person has lung cancer. If the predicted probability of a person 
is above 0.589, this person is predicted to have lung cancer. If the predicted probability of a 
person is below 0.589, this person is predicted to have no lung cancer. The area under the 
ROC curve is 0.9792, indicating this test method is excellent. 
 
Figure 5-8 ROC curve of the model 
 
 
Table 5-7 Relationship between cut-off probability and sensitivity, 1-specificity, 
distance to the point of (0, 1), and Youden index 
 
Obs _PROB_ _SENSIT_ _1MSPEC_ DIST to (0,1) Youden index 
1 1.000  0.08  0.00  0.92  0.08  
2 1.000  0.17  0.00  0.83  0.17  
3 1.000  0.25  0.00  0.75  0.25  
4 1.000  0.33  0.00  0.67  0.33  
5 1.000  0.42  0.00  0.58  0.42  
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6 1.000  0.50  0.00  0.50  0.50  
7 1.000  0.58  0.00  0.42  0.58  
8 0.929  0.67  0.00  0.33  0.67  
9 0.926  0.75  0.00  0.25  0.75  
10 0.863  0.75  0.08  0.26  0.67  
11 0.753  0.83  0.08  0.19  0.75  
12 0.676  0.92  0.08  0.12  0.83  
13 0.589  1.00  0.08  0.08  0.92  
14 0.146  1.00  0.17  0.17  0.83  
15 0.104  1.00  0.25  0.25  0.75  
16 0.013  1.00  0.33  0.33  0.67  
17 0.001  1.00  0.42  0.42  0.58  
18 0.000  1.00  0.50  0.50  0.50  
19 0.000  1.00  0.58  0.58  0.42  
20 0.000  1.00  0.67  0.67  0.33  
21 0.000  1.00  0.75  0.75  0.25  
22 0.000  1.00  0.83  0.83  0.17  
23 0.000  1.00  0.92  0.92  0.08  
24 0.000  1.00  1.00  1.00  0.00  
 
When the cut-off probability is set to be 0.589, the relationship between the predicted 
existence of lung cancer and the actual diagnosis is shown in Figure 5-9. One person in the 
control group is predicted to have lung cancer, whereas, no person in the case group is 
predicted to have no lung cancer. The sensitivity and specificity for this test is 1.00 and 0.92, 
respectively. Table 5-8 summarizes how many persons are predicted to have lung cancer 
and how many persons are predicted to have no lung cancer for patients in different stages. 
 
Table 5-8 Prediction of existence of lung cancer for patients at different stages 
  Predicted 
  No Yes 
C 11 1 
I 0 1 
II 0 6 
III 0 5 
 
 
 
 
 
 
 
Figure 5-9 Prediction of existence of cancer based on the optimal cut-off probability 
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 5.3.3 Comparison of models in section 5.2.1 and 5.2.2 
Table 5-9 compares the probabilities calculated by the models in section 5.2.1 (average 
MMP is used as the predictor) and section 5.2.2 (average MMP and age are used as the 
predictors). The probabilities calculated by the two models are similar for all the persons.  
 
Table 5-9 Comparison of probabilities of having lung cancer for each patient between 
the two models in section 5.2.1 and 5.2.2 
Obs Patient Age Staging average MMP Cancer Prob1 Prob2 
1 C1 47 C 0.45603 No 0.001  0.001  
2 C10 60 C 0.29954 No 0.000  0.000  
3 C11 26 C 0.36683 No 0.000  0.000  
4 C12 44 C 0.41336 No 0.000  0.000  
5 C2 51 C 0.32572 No 0.000  0.000  
6 C3 28 C 0.51654 No 0.007  0.013  
7 C4 32 C 0.61482 No 0.095  0.146  
8 C5 62 C 0.64015 No 0.174  0.104  
9 C6 48 C 0.76616 No 0.866  0.864  
10 C7 49 C 0.33458 No 0.000  0.000  
11 C8 26 C 0.34843 No 0.000  0.000  
12 C9 42 C 0.30096 No 0.000  0.000  
13 L1 27 II 1.01316 Yes 1.000  1.000  
14 L10 49 II 0.72741 Yes 0.693  0.676  
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15 L11 40 III 0.72932 Yes 0.704  0.753  
16 L12 50 II 0.71529 Yes 0.619  0.590  
17 L2 44 III 1.04613 Yes 1.000  1.000  
18 L3 63 II 1.00416 Yes 1.000  1.000  
19 L4 54 III 1.03366 Yes 1.000  1.000  
20 L5 37 II 0.77618 Yes 0.895  0.926  
21 L6 46 III 1.07635 Yes 1.000  1.000  
22 L7 51 I 1.04785 Yes 1.000  1.000  
23 L8 38 II 0.97629 Yes 0.999  1.000  
24 L9 55 III 0.80185 Yes 0.945  0.930  
 
Table 5-10 summarizes the differences of the two models in the diagnostic test of lung 
cancer. Including age does not have much effect on the area under the ROC curve, optimal 
cut-off probability, sensitivity, specificity, or p-value for average MMP. The comparison is 
also shown in Figure 5-10. 
 
Table 5-10 Comparison of models in section 5.2.1 and 5.2.2 
Predictor Area under Threshold Sensi Speci P-value 
  the ROC curve       MMP Age 
AverageCath 0.9792 0.619 1 0.92 0.1146 N/A 
AverageCath+Age 0.9792 0.589 1 0.92 0.1037 0.7574 
 
 
Figure 5-10 Prediction of existence of cancer based on the optimal cut-off probability 
for the models used in section 5.2.1 and 5.2.2 
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 5.4 Analysis based on multicategory logistic model 
In this section, average MMP and age are used as the predictors to predict the probabilities 
of each stage of cancer for different persons. Analysis of effects of different parameters is 
shown in Table 5-11. Estimates of parameters are shown in Table 5-12. Table 5-12 lists the 
intercepts and coefficients of the three equations fit for the three cancer stages, I, II, and III. 
The intercept and coefficient of the equation for control group (including healthy persons 
and the patients with breast cancer of stage 0) are set to be 0 by default. Probabilities of 
each stage of lung cancer for different persons are computed and shown in Table 5-13. For 
example, the first line of Table 5-13 indicates the first patient has no lung cancer. Based on 
the diagnostic test, the probability that he or she has no lung cancer is 0.999. The 
probability that he or she is at stage I, II, or III is 0.000, 0.001, and 0.000, respectively.  The 
p-values of average MMP and age are 0.3207 and 0.8878. 
 
Table 5-11 Analysis of Effects 
Effect DF Chi-Square Pr > ChiSq 
average 
MMP 
3 3.5006 0.3207 
Age 3 0.6803 0.8778 
 
Table 5-12 Intercepts and coefficients of the logistic regression equations fit for the 
three cancer stages 
Standard 
Staging DF Estimate Error Chi-Square Pr > ChiSq 
Parameter 
Intercept III 1 -22.4031 13.0225 2.9596 0.0854 
Intercept II 1 -16.9139 12.0692 1.964 0.1611 
Intercept I 1 -75.3616 104.6 0.5193 0.4711 
average MMP III 1 30.57 17.5026 3.0506 0.0807 
average MMP II 1 26.9478 17.0712 2.4918 0.1144 
average MMP I 1 74.639 86.9727 0.7365 0.3908 
Age III 1 -0.00405 0.128 0.001 0.9748 
Age II 1 -0.0484 0.1198 0.1634 0.686 
Age I 1 0.1129 0.352 0.1028 0.7485 
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Table 5-13 Probabilities of lung cancer in each stage for each patient 
Obs Age Staging averageMMP 
Prob of no 
cancer 
Prob of 
stage I 
Prob of 
stage II 
Prob of 
stage III 
1 47 C 0.45603 0.999  0.000  0.001  0.000  
2 51 C 0.32572 1.000  0.000  0.000  0.000  
3 28 C 0.51654 0.986  0.000  0.013  0.001  
4 32 C 0.61482 0.852  0.000  0.128  0.020  
5 62 C 0.64015 0.897  0.000  0.062  0.041  
6 48 C 0.76616 0.136  0.000  0.555  0.309  
7 49 C 0.33458 1.000  0.000  0.000  0.000  
8 26 C 0.34843 1.000  0.000  0.000  0.000  
9 42 C 0.30096 1.000  0.000  0.000  0.000  
10 60 C 0.29954 1.000  0.000  0.000  0.000  
11 26 C 0.36683 1.000  0.000  0.000  0.000  
12 44 C 0.41336 1.000  0.000  0.000  0.000  
13 27 II 1.01316 0.000  0.002  0.649  0.349  
14 44 III 1.04613 0.000  0.092  0.397  0.511  
15 63 II 1.00416 0.000  0.159  0.236  0.605  
16 54 III 1.03366 0.000  0.181  0.281  0.538  
17 37 II 0.77618 0.075  0.000  0.683  0.242  
18 46 III 1.07635 0.000  0.346  0.255  0.400  
19 51 I 1.04785 0.000  0.220  0.282  0.498  
20 38 II 0.97629 0.000  0.002  0.565  0.433  
21 55 III 0.80185 0.066  0.000  0.501  0.433  
22 49 II 0.72741 0.326  0.000  0.448  0.226  
23 40 III 0.72932 0.250  0.000  0.559  0.191  
24 50 II 0.71529 0.413  0.000  0.390  0.197  
 
For each person, the stage of cancer is predicted to be the one with the largest probability. 
As a summary, table 5-14 lists the numbers of persons predicted to be lung cancers of 
different stages. 
 
Table 5-14 Prediction of staging of lung cancer for patients in different stages of lung 
cancer 
 
Predicted Staging 
Staging C II III Sum 
C 11 1 
 
12 
I 
  
1 1 
II 1 4 1 6 
III 
 
2 3 5 
Sum 12 7 5 24 
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 5.5 Analysis based on CART 
The data are also analyzed by a classification tree. These patients are divided into two 
groups based on the method used in section 5.3. If the patient has no lung cancer, he is in 
the no lung cancer group. If the patient has lung cancer at stage I, II, or III, he is in the lung 
cancer group. The output is shown in Figure 5-11.  If the average MMP is greater than 
0.6777, the patient is predicted to have lung cancer. On the contrary, if the average MMP of 
the individual is smaller than 0.6777, the individual is predicted to have no lung cancer. 
Only one person without lung cancer is predicted to have lung cancer. The prediction is 
correct for the other persons. The prediction for each patient is in Table 5-16.  
 
Figure 5-11 Predicted lung cancer condition by tree model 
 
Table 5-15 Predicted lung cancer condition by tree model 
Patient Age Staging MMP1(1) MMP1(2) MMP1(3) 
Average 
MMP 
Cancer 
C1 47 C 0.430  0.460  0.478  0.456  No 
C2 51 C 0.308  0.329  0.340  0.326  No 
C3 28 C 0.515  0.505  0.530  0.517  No 
C4 32 C 0.612  0.609  0.624  0.615  No 
C5 62 C 0.624  0.651  0.645  0.640  No 
C6 48 C 0.769  0.756  0.773  0.766  Yes 
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C7 49 C 0.308  0.357  0.338  0.335  No 
C8 26 C 0.356  0.301  0.389  0.348  No 
C9 42 C 0.297  0.305  0.300  0.301  No 
C10 60 C 0.289  0.310  0.300  0.300  No 
C11 26 C 0.356  0.378  0.367  0.367  No 
C12 44 C 0.404  0.413  0.423  0.413  No 
L1 27 II 0.977  1.094  0.968  1.013  Yes 
L2 44 III 1.084  1.055  1.000  1.046  Yes 
L3 63 II 1.009  1.027  0.976  1.004  Yes 
L4 54 III 0.997  1.057  1.047  1.034  Yes 
L5 37 II 0.799  0.756  0.773  0.776  Yes 
L6 46 III 1.138  1.063  1.028  1.076  Yes 
L7 51 I 1.067  1.048  1.028  1.048  Yes 
L8 38 II 1.007  0.967  0.955  0.976  Yes 
L9 55 III 0.813  0.789  0.803  0.802  Yes 
L10 49 II 0.727  0.753  0.703  0.727  Yes 
L11 40 III 0.691  0.767  0.729  0.729  Yes 
L12 50 II 0.689  0.714  0.743  0.715  Yes 
 
The prediction for patients with or without lung cancer is illustrated in Figure 5-12. It can 
be seen that no patient with lung cancer is predicted to have lung cancer, whereas, one 
person without lung cancer is predicted to have lung cancer. 
 
Figure 5-12 Scatter plot of enzyme pattern vs existence of lung cancer 
 
It needs to be noted that the number of wrongly predicted person is the same as the 
number of wrongly predicted persons in the logistic regression model when average MMP 
is used as the predictor and this grouping is used (model in section 5.2.1). 
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Chapter 6 - Conclusion 
This report illustrates how to use the method of logistic regression or the method of CART to 
investigate the performance of a new method developed by Dr. Bossmann and his coworkers in 
Kansas State University. It is found that the performance of these diagnostic tests is very good on 
these particular datasets, given that the area under the ROC curve is greater than 0.9. The 
nanoparticles developed by Dr. Bossmann’s group appear to show promise in detecting breast 
cancer and lung cancer. Including the factor of patient’s age helps to predict the existence of breast 
cancer for the samples used in this report. But since the samples sizes are small, it is impossible to 
conclude that including the age variable in the model helps the prediction of breast cancer. Logistic 
regression gives a better prediction than CART when age is included as one of the predictors. But 
the ability of these particles to predict the actual stages of cancer is low.  
 
The results of this study have some limitations. First, data are obtained by observational study, and 
the persons involved in this study are not randomly chosen. Second, sample sizes are small. Third, 
though the performance of the test seems good, there are still false positives and negatives for some 
patients. 
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Appendix A - SAS and R codes 
SAS code for section 3.2 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
proc print data=breast; 
run; 
data breastnew; 
      set breast; 
          if Staging="C" then level="moderate"; 
          else if Staging="0" then level="moderate"; 
          else if Staging="I" then level="moderate"; 
          else if Staging="II" then level="moderate"; 
          else if Staging="III" then level="severe"; 
          else if Staging="IV" then level="severe"; 
run; 
proc logistic descending; 
   model level=CathB1 Age; 
run; 
data probability1; 
   set breastnew(keep=Patient CathB1 Age staging level); 
   alpha1=-10.3277; 
   beta1=3.336*0.000001; 
   gamma1=0.0953; 
   probability1=exp(alpha1+beta1*CathB1+gamma1*Age)/(1+exp(alpha1+beta1*CathB1+gamma1*Age)); 
run; 
proc logistic descending; 
   model level=CathB2 Age; 
run; 
data probability2; 
   set breastnew(keep=Patient CathB2 Age staging level); 
   alpha2=-10.1293; 
   beta2=3.389*0.000001; 
   gamma2=0.0922; 
probability2=exp(alpha2+beta2*CathB2+gamma2*Age)/(1+exp(alpha2+beta2*CathB2+gamma2*Age)); 
run; 
proc logistic descending; 
   model level=CathB3 Age; 
run; 
data probability3; 
   set breastnew(keep=Patient CathB3 Age staging level); 
   alpha3=-9.6663; 
   beta3=3.407*0.000001; 
   gamma3=0.0837; 
probability3=exp(alpha3+beta3*CathB3+gamma3*Age)/(1+exp(alpha3+beta3*CathB3+gamma3*Age)); 
run; 
proc sort data=probability1; 
      by Patient; 
run; 
proc sort data=probability2; 
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      by Patient; 
run; 
proc sort data=probability3; 
      by Patient; 
run; 
data comparison; 
merge probability1 probability2 probability3; 
by Patient; 
keep Patient  Age Staging level probability1 probability2 probability3; 
run; 
proc print data=comparison; 
run; 
ODS CSV file="D:\master report\comparison of three probabilities.csv";  
proc print data=comparison;  
run;  
ODS CSV close;  
run; 
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SAS code for section 3.3.1 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then Cancer="moderate"; 
          else if Staging="0" then delete; 
          else if Staging="I" then delete; 
          else if Staging="II" then Cancer="severe"; 
          else if Staging="III" then Cancer="severe"; 
          else if Staging="IV" then Cancer="severe"; 
run; 
proc logistic descending; 
   model Cancer=CathB/outroc=roc; 
run; 
data probability; 
   set breastnew(keep=Patient CathB Age staging Cancer); 
   probability=exp(-2.8809+0.000002532*CathB)/(1+exp(-2.8809+0.000002532*CathB)); 
ODS CSV file="D:\master report\master report\ averageCathB as predictors for CathB (stage 0 and I 
deleted).csv";  
proc print data=probability;  
run;  
ODS CSV close;  
run; 
 
ODS CSV file="D:\master report\ROC\ROC3.4.1.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
run; 
ods graphics on; 
ods html; 
proc logistic data=breastnew desc plots(only)=(roc); 
model Cancer =CathB; 
run; 
ods html close; 
ods graphics off; 
run; 
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SAS code for section 3.3.2 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then Cancer ="moderate"; 
          else if Staging="0" then delete; 
          else if Staging="I" then delete; 
          else if Staging="II" then Cancer ="severe"; 
          else if Staging="III" then Cancer ="severe"; 
          else if Staging="IV" then Cancer ="severe"; 
run; 
proc logistic descending; 
   model Cancer =CathB Age/outroc=roc; 
run; 
data probability; 
   set breastnew(keep=Patient CathB Age staging Cancer); 
probability=exp(-6.2938+0.000002073*CathB+0.0785*Age)/(1+exp(-
6.2938+0.000002073*CathB+0.0785*Age)); 
ODS CSV file="D:\master report\master report\ averageCathB and age as predictors for CathB (stage 0 and I 
deleted).csv";  
proc print data=probability;  
run;  
ODS CSV close;  
run; 
 
ODS CSV file="D:\master report\ROC\ROC3.4.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
run; 
ods graphics on; 
ods html; 
proc logistic data=breastnew desc plots(only)=(roc); 
model Cancer =CathB Age; 
run; 
ods html close; 
ods graphics off; 
run; 
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SAS code for section 3.4.1 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then level="moderate"; 
          else if Staging="0" then level="moderate"; 
          else if Staging="I" then level="moderate"; 
          else if Staging="II" then delete; 
          else if Staging="III" then level="severe"; 
          else if Staging="IV" then level="severe"; 
run; 
proc logistic descending; 
   model level=CathB/covb outroc=roc; 
run; 
data probability; 
   set breastnew(keep=Patient CathB staging level); 
   alpha=-4.8059; 
   beta=3.381*0.000001; 
   probability=exp(alpha+beta*CathB)/(1+exp(alpha+beta*CathB)); 
   varalpha=3.060474; 
   varbeta=1.59*0.000000000001; 
   cov=-2.05*0.000001; 
   SE=sqrt(varalpha+CathB*CathB*varbeta+2*CathB*cov); 
   lower=alpha+beta*CathB-1.96*SE; 
   upper=alpha+beta*CathB+1.96*SE; 
   lowerpro=exp(lower)/(1+exp(lower)); 
   upperpro=exp(upper)/(1+exp(upper)); 
run; 
proc print data=probability (keep=Patient Staging level probability lowerpro upperpro); 
run; 
ODS CSV file="D:\master report\master report\ averageCathB as predictors for CathB (stage II deleted).csv";  
proc print data=probability;  
run;  
ODS CSV close;  
run; 
ODS CSV file="D:\master report\ROC\ROC3.3.1.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
run; 
ods graphics on; 
ods html; 
proc logistic data=breastnew desc plots(only)=(roc); 
model level=CathB; 
run; 
ods html close; 
ods graphics off; 
run; 
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SAS code for section 3.4.2 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then level="moderate"; 
          else if Staging="0" then level="moderate"; 
          else if Staging="I" then level="moderate"; 
          else if Staging="II" then delete; 
          else if Staging="III" then level="severe"; 
          else if Staging="IV" then level="severe"; 
run; 
proc logistic descending; 
   model level=CathB Age/outroc=roc; 
run; 
data probability2; 
   set breastnew(keep=Patient CathB Age staging level); 
   probability2=exp(-9.4669+3.254*0.000001*CathB+0.0879*Age)/(1+exp(-
9.4669+3.254*0.000001*CathB+0.0879*Age)); 
proc print data=probability2; 
run; 
ODS CSV file="D:\master report\master report\ averageMMP and age as predictors for CathB.csv";  
proc print data=probability2;  
run;  
ODS CSV close;  
run; 
 
ODS CSV file="D:\master report\ROC\ROC3.3.2.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
run; 
ods graphics on; 
ods html; 
proc logistic data=breastnew desc plots(only)=(roc); 
model level=CathB Age; 
run; 
ods html close; 
ods graphics off; 
run; 
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SAS code for section 3.4.3 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then level="moderate"; 
          else if Staging="0" then level="moderate"; 
          else if Staging="I" then level="moderate"; 
          else if Staging="II" then delete; 
          else if Staging="III" then level="severe"; 
          else if Staging="IV" then level="severe"; 
run; 
proc logistic descending; 
   model level=CathB/covb; 
run; 
data probability; 
   set breastnew(keep=Patient CathB staging level); 
   alpha=-4.8059; 
   beta=3.381*0.000001; 
   probability=exp(alpha+beta*CathB)/(1+exp(alpha+beta*CathB)); 
run; 
proc logistic descending; 
   model level=CathB Age; 
run; 
data probability2; 
   set breastnew(keep=Patient CathB Age staging level); 
probability2=exp(-9.4669+3.254*0.000001*CathB+0.0879*Age)/(1+exp(-
9.4669+3.254*0.000001*CathB+0.0879*Age)); 
proc sort data=probability; 
      by Patient; 
run; 
proc sort data=probability2; 
      by Patient; 
run; 
data comparison; 
merge probability probability2; 
by Patient; 
keep Patient CathB Age Staging level probability probability2; 
run; 
ODS CSV file="D:\master report\comparison(Stage II delete).csv";  
proc print data=comparison;  
run;  
ODS CSV close;  
run; 
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SAS code for section 3.5.1 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then level="moderate"; 
          else if Staging="0" then level="moderate"; 
          else if Staging="I" then level="moderate"; 
          else if Staging="II" then level="moderate"; 
          else if Staging="III" then level="severe"; 
          else if Staging="IV" then level="severe"; 
run; 
proc logistic descending; 
   model level=CathB/outroc=roc; 
run; 
data probability; 
   set breastnew(keep=Patient CathB staging level); 
probability=exp(-5.2329+3.535*0.000001*CathB)/(1+exp(-5.2329+3.535*0.000001*CathB)); 
proc print data=probability; 
run; 
ODS CSV file="D:\master report\master report\ averageCathB as predictors for CathB (complete data).csv";  
proc print data=probability;  
run;  
ODS CSV close;  
run; 
ODS CSV file="D:\master report\ROC\ROC3.4.1.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
ods graphics on; 
ods html; 
proc logistic data=probability desc plots(only)=(roc); 
model level=CathB; 
run; 
ods html close; 
ods graphics off; 
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SAS code for section 3.5.2 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then level="moderate"; 
          else if Staging="0" then level="moderate"; 
          else if Staging="I" then level="moderate"; 
          else if Staging="II" then level="moderate"; 
          else if Staging="III" then level="severe"; 
          else if Staging="IV" then level="severe"; 
run; 
proc logistic descending; 
   model level=CathB Age/outroc=roc; 
run; 
data probability2; 
   set breastnew(keep=Patient CathB Age staging level); 
probability2=exp(-9.9959+3.374*0.000001*CathB+0.0898*Age)/(1+exp(-
9.9959+3.374*0.000001*CathB+0.0898*Age)); 
proc print data=probability2; 
run; 
ODS CSV file="D:\master report\averageCathB and age as predictor(complete data).csv";  
proc print data=probability2;  
run;  
ODS CSV close;  
ODS CSV file="D:\master report\ROC\ROC3.4.2.csv";  
proc print data=roc;  
run;  
ODS CSV close; 
run; 
ods graphics on; 
ods html; 
proc logistic data=breastnew plots(only)=(roc); 
model level=CathB Age; 
run; 
ods html close; 
ods graphics off; 
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SAS code for section 3.5.3 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
      if Staging="C" then level="moderate"; 
          else if Staging="0" then level="moderate"; 
          else if Staging="I" then level="moderate"; 
          else if Staging="II" then level="moderate"; 
          else if Staging="III" then level="severe"; 
          else if Staging="IV" then level="severe"; 
run; 
proc logistic descending; 
   model level=CathB; 
run; 
data probability; 
   set breastnew(keep=Patient CathB staging level); 
probability=exp(-5.2329+3.535*0.000001*CathB)/(1+exp(-5.2329+3.535*0.000001*CathB)); 
proc logistic descending; 
   model level=CathB Age; 
run; 
data probability2; 
   set breastnew(keep=Patient CathB Age staging level); 
probability2=exp(-9.9959+3.374*0.000001*CathB+0.0898*Age)/(1+exp(-
9.9959+3.374*0.000001*CathB+0.0898*Age)); 
proc sort data=probability; 
      by Patient; 
run; 
proc sort data=probability2; 
      by Patient; 
run; 
data comparison; 
merge probability probability2; 
by Patient; 
keep Patient CathB Age Staging level probability probability2; 
run; 
proc print data=comparison; 
run; 
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SAS code for section 3.6 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\breast cancer.xls" 
       dbms=xls replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      CathB=1/3*(CathB1 +CathB2+CathB3); 
   if Staging="0" then Staging="C"; 
run; 
proc logistic descending; 
   model Staging=CathB Age/link=glogit; 
run; 
data probability; 
   set breastnew(keep=Patient CathB Staging Age); 
   alpha1=-12.3027; beta1=-0.00000334;   gamma1=0.2163; 
   alpha2=-4.7017;  beta2= 0.0000005452; gamma2=0.0581; 
   alpha3=-11.3583; beta3= 0.000002923;  gamma3=0.1295; 
   alpha4=-14.1369; beta4= 0.000003849;  gamma4= 0.1430; 
   sum=exp(alpha1+beta1*CathB+gamma1*Age)+exp(alpha2+beta2*CathB+gamma2*Age)+ 
   exp(alpha3+beta3*CathB+gamma3*Age)+exp(alpha4+beta4*CathB+gamma4*Age)+1; 
   PI=exp(alpha1+beta1*CathB+gamma1*Age)/sum; 
   PII=exp(alpha2+beta2*CathB+gamma2*Age)/sum; 
   PIII=exp(alpha3+beta3*CathB+gamma3*Age)/sum; 
   PIV=exp(alpha4+beta4*CathB+gamma4*Age)/sum; 
   PC=1-PI-PII-PIII-PIV; 
run; 
ODS CSV file="D:\master report\multi-stages probability for CathB.csv";  
proc print data=probability (keep = CathB Staging Age PI PII PIII PIV PC); 
run;  
ODS CSV close;  
run; 
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R code for section3.8 
# install rpart library 
chooseCRANmirror() 
install.packages("rpart") 
library(rpart) 
 
#read data 
CathB=read.csv("D:master report\\CathB-revised.csv") 
B1=CathB[1:32,] #These are the breast cancer and control data 
averageCath=1/3*(B1[,5]+B1[,6]+B1[,7]) 
B2=cbind(B1, averageCath) 
 
#tree classification 
fit <- rpart(Staging ~ averageCath + Age, 
    method="class", data=B1) 
printcp(fit) # display the results  
plotcp(fit) # visualize cross-validation results  
summary(fit) # detailed summary of splits 
 
# plot tree  
plot(fit, uniform=TRUE,  
    main="Classification Tree for CathB") 
text(fit, use.n=TRUE, all=TRUE, cex=.8) 
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SAS code for section 4.2 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\master report\breast cancer\MP1breast.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
proc print data=breast; 
run; 
data breastnew; 
      set breast; 
          if Staging="C" then Cancer="No"; 
          else if Staging="0" then Cancer="No"; 
          else if Staging="I" then Cancer ="Yes"; 
          else if Staging="II" then Cancer ="Yes"; 
          else if Staging="III" then Cancer ="Yes"; 
          else if Staging="IV" then Cancer ="Yes"; 
run; 
proc logistic descending; 
   model Cancer=MMP11 Age; 
run; 
data probability1; 
   set breastnew(keep=Patient MMP11 Age staging Cancer); 
   alpha1=-10.3277; 
   beta1=3.336*0.000001; 
   gamma1=0.0953; 
   probability1=exp(alpha1+beta1*MMP111+gamma1*Age)/(1+exp(alpha1+beta1*MMP11+gamma1*Age)); 
run; 
proc logistic descending; 
   model Cancer=MMP12 Age; 
run; 
data probability2; 
   set breastnew(keep=Patient MMP12 Age staging Cancer); 
   alpha2=-10.1293; 
   beta2=3.389*0.000001; 
   gamma2=0.0922; 
probability2=exp(alpha2+beta2*MMP12+gamma2*Age)/(1+exp(alpha2+beta2*MMP12+gamma2*Age)); 
run; 
proc logistic descending; 
   model Cancer=MMP13 Age; 
run; 
data probability3; 
   set breastnew(keep=Patient MMP13 Age staging Cancer); 
   alpha3=-9.6663; 
   beta3=3.407*0.000001; 
   gamma3=0.0837; 
probability3=exp(alpha3+beta3*MMP13+gamma3*Age)/(1+exp(alpha3+beta3*MMP13+gamma3*Age)); 
run; 
proc sort data=probability1; 
      by Patient; 
run; 
proc sort data=probability2; 
      by Patient; 
run; 
proc sort data=probability3; 
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      by Patient; 
run; 
data comparison; 
merge probability1 probability2 probability3; 
by Patient; 
keep Patient  Age Staging Cancer probability1 probability2 probability3; 
run; 
proc print data=comparison; 
run; 
ODS CSV file="D:\master report\comparison of three probabilities for breast cancer (MP1).csv";  
proc print data=comparison;  
run;  
ODS CSV close;  
run; 
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SAS code for section 4.3.1 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\master report\breast cancer\MP1breast.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      MMP=1/3*(MMP11 +MMP12+MMP13); 
      if Staging="C" then Cancer="No"; 
          else if Staging="0" then Cancer="No"; 
          else if Staging="I" then Cancer ="Yes"; 
          else if Staging="II" then Cancer ="Yes"; 
          else if Staging="III" then Cancer ="Yes"; 
          else if Staging="IV" then Cancer ="Yes"; 
run; 
proc logistic descending; 
   model Cancer =MMP/outroc=roc; 
run; 
data probability; 
   set breastnew(keep=Patient MMP Age staging Cancer); 
probability=exp(-6.5605+11.5520*MMP)/(1+exp(-6.5605+11.5520*MMP)); 
proc print data=probability; 
run; 
ODS CSV file="D:\master report\master report\breast cancer\averageCathB as predictor(MP1).csv";  
proc print data=probability;  
run;  
ODS CSV close;  
ODS CSV file="D:\master report\ROC\ROC5.3.1.csv";  
proc print data=roc;  
run;  
ODS CSV close; 
ods graphics on; 
ods html; 
proc logistic data=breastnew plots(only)=(roc); 
     model Cancer =MMP; 
     run; 
ods html close; 
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SAS code for section 4.3.2 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\master report\breast cancer\MP1breast.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      MMP=1/3*(MMP11 +MMP12+MMP13); 
      if Staging="C" then Cancer="No"; 
          else if Staging="0" then Cancer="No"; 
          else if Staging="I" then Cancer ="Yes"; 
          else if Staging="II" then Cancer ="Yes"; 
          else if Staging="III" then Cancer ="Yes"; 
          else if Staging="IV" then Cancer ="Yes"; 
run; 
proc logistic descending; 
   model Cancer=MMP Age/outroc=roc; 
run; 
data probability; 
   set breastnew(keep=Patient MMP Age staging Cancer); 
probability=exp(-10.5871+10.2277*MMP+0.0970*Age)/(1+exp(-10.5871+10.2277*MMP+0.0970*Age)); 
proc print data=probability; 
run; 
ODS CSV file="D:\master report\master report\breast cancer\averageCathB and age as predictor(MP1).csv";  
proc print data=probability;  
run;  
ODS CSV close;  
ODS CSV file="D:\master report\ROC\ROC5.3.2.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
ods graphics on; 
ods html; 
proc logistic data=breastnew plots(only)=(roc); 
     model Cancer=MMP Age; 
     run; 
ods html close; 
ods graphics off; 
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SAS code for section 4.4 
options nodate nonumber; 
proc import out =work.breast datafile="D:\master report\master report\breast cancer\MP1breast.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
data breastnew; 
      set breast; 
      averageMMP=1/3*(MMP11 +MMP12+MMP13); 
      if Staging="0" then Staging="C"; 
run; 
proc logistic descending; 
   model Staging=averageMMP Age/link=glogit; 
run; 
data probability; 
   set breastnew(keep=Patient averageMMP Age staging); 
   alpha1=-17.8201; beta1=10.8368;   gamma1=0.1704; 
   alpha2=-9.1344;  beta2= 8.9862;   gamma2=0.0552; 
   alpha3=-13.4324; beta3= 11.6952;  gamma3=0.1094; 
   alpha4=-12.1065; beta4= 10.1164;  gamma4=0.1101; 
   sum=exp(alpha1+beta1*averageMMP+gamma1*Age)+exp(alpha2+beta2*averageMMP+gamma2*Age)+ 
   exp(alpha3+beta3*averageMMP+gamma3*Age)+exp(alpha4+beta4*averageMMP+gamma4*Age)+1; 
   PI=exp(alpha1+beta1*averageMMP+gamma1*Age)/sum; 
   PII=exp(alpha2+beta2*averageMMP+gamma2*Age)/sum; 
   PIII=exp(alpha3+beta3*averageMMP+gamma3*Age)/sum; 
   PIV=exp(alpha4+beta4*averageMMP+gamma4*Age)/sum; 
   PC=1-PI-PII-PIII-PIV; 
run; 
 
ODS CSV file="D:\master report\master report\breast cancer\averageMMP and age as predictor for 
multicategory response.csv";  
proc print data=probability (keep=averageMMP Staging Age PI PII PIII PIV PC);  
run;  
ODS CSV close;  
run; 
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R code for section 4.5 
library(rpart) 
MP1=read.csv("D:master report\\MP1-revised.csv") 
B1=MP1[1:32,] #These are the breast cancer and control data 
averageMMP=1/3*(B1[,5]+B1[,6]+B1[,7]) 
B2=cbind(B1, averageMMP) 
 
#tree classification 
fit <- rpart(Staging ~ averageMMP + Age, 
    method="class", data=B1) 
printcp(fit) # display the results  
plotcp(fit) # visualize cross-validation results  
summary(fit) # detailed summary of splits 
 
# plot tree  
plot(fit, uniform=TRUE,  
    main="Classification Tree for MMPbreast") 
text(fit, use.n=TRUE, all=TRUE, cex=.8) 
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SAS code for section 5.3.1 
proc import out =work.lung datafile="D:\master report\master report\lung cancer\MP1lungcancer.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
data lungnew; 
      set lung; 
      averageMMP=1/3*(MMP11 +MMP12+MMP13); 
      if Staging="C" then Cancer="No"; 
          else if Staging="I" then Cancer="Yes"; 
          else if Staging="II" then Cancer="Yes"; 
          else if Staging="III" then Cancer="Yes"; 
run; 
proc logistic descending; 
   model Cancer=averageMMP/outroc=roc; 
run; 
data probability; 
   set lungnew(keep=Patient averageMMP staging Cancer); 
probability=exp(-18.9824+27.2166*averageMMP)/(1+exp(-18.9824+27.2166*averageMMP)); 
ODS CSV file="D:\master report\master report\lung cancer\averageMMP as predictor.csv";  
proc print data=probability;  
run;  
ODS CSV close;  
ODS CSV file="D:\master report\ROC\ROC4.3.1.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
 
ods graphics on; 
ods html; 
proc logistic data=lungnew desc plots(only)=(roc); 
     model Cancer=averageMMP; 
     run; 
ods html close; 
ods graphics off; 
run; 
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SAS code for section 5.3.2 
options nodate nonumber; 
proc import out =work.lung datafile="D:\master report\master report\lung cancer\MP1lungcancer.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
data lungnew; 
      set lung; 
      averageMMP=1/3*(MMP11 +MMP12+MMP13); 
      if Staging="C" then Cancer="No"; 
          else if Staging="I" then Cancer="Yes"; 
          else if Staging="II" then Cancer="Yes"; 
          else if Staging="III" then Cancer="Yes"; 
run; 
proc logistic descending; 
   model Cancer=averageMMP Age/outroc=roc; 
run; 
data probability2; 
   set lungnew(keep=Patient averageMMP Age staging Cancer); 
probability2=exp(-17.6394+27.7137*averageMMP-0.0364*Age)/(1+exp(-
17.6394+27.7137*averageMMP-0.0364*Age)); 
ODS CSV file="D:\master report\master report\lung cancer\averageMMP and Age as predictor.csv";  
proc print data=probability2;  
run;  
ODS CSV close;  
ODS CSV file="D:\master report\ROC\ROC4.3.2.csv";  
proc print data=roc;  
run;  
ODS CSV close;  
ods graphics on; 
ods html; 
proc logistic data=lungnew plots(only)=(roc); 
     model Cancer=averageMMP Age; 
     run; 
ods html close; 
ods graphics off; 
run; 
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SAS code for section 5.3.3 
proc import out =work.lung datafile="D:\master report\master report\lung cancer\MP1lungcancer.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
data lungnew; 
      set lung; 
      averageMMP=1/3*(MMP11 +MMP12+MMP13); 
      if Staging="C" then Cancer="No"; 
          else if Staging="I" then Cancer="Yes"; 
          else if Staging="II" then Cancer="Yes"; 
          else if Staging="III" then Cancer="Yes"; 
run; 
proc logistic descending; 
   model Cancer=averageMMP; 
run; 
data probability; 
   set lungnew(keep=Patient averageMMP staging Cancer); 
probability=exp(-18.9824+27.2166*averageMMP)/(1+exp(-18.9824+27.2166*averageMMP)); 
run; 
proc logistic descending; 
   model Cancer=averageMMP Age; 
run; 
data probability2; 
   set lungnew(keep=Patient averageMMP Age staging Cancer); 
probability2=exp(-17.6394+27.7137*averageMMP-0.0364*Age)/(1+exp(-
17.6394+27.7137*averageMMP-0.0364*Age)); 
run; 
proc sort data=probability; 
      by Patient; 
run; 
proc sort data=probability2; 
      by Patient; 
run; 
data comparison; 
merge probability probability2; 
by Patient; 
keep Patient averageMMP Age Staging Cancer probability probability2; 
run; 
ODS CSV file="D:\master report\master report\lung cancer\comparison.csv";  
proc print data=comparison;  
run;  
ODS CSV close;  
run; 
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SAS code for section 5.4 
options nodate nonumber; 
proc import out =work.lung datafile="D:\master report\master report\lung cancer\MP1lungcancer.csv" 
       dbms=csv replace; 
    getnames=yes; 
run; 
data lungnew; 
      set lung; 
      averageMMP=1/3*(MMP11 +MMP12+MMP13); 
run; 
proc logistic descending; 
   model Staging=averageMMP Age/link=glogit; 
run; 
data probability; 
   set lungnew(keep=Patient averageMMP Age Staging); 
   alpha1=-75.3616; beta1=74.6390;   gamma1=0.1129; 
   alpha2=-16.9139;  beta2= 26.9478; gamma2=-0.0484; 
   alpha3=-22.4031; beta3= 30.5700;  gamma3=-0.00405; 
   sum=exp(alpha1+beta1*averageMMP+gamma1*Age)+exp(alpha2+beta2*averageMMP+gamma2*Age)+ 
   exp(alpha3+beta3*averageMMP+gamma3*Age)+1; 
   PI=exp(alpha1+beta1*averageMMP+gamma1*Age)/sum; 
   PII=exp(alpha2+beta2*averageMMP+gamma2*Age)/sum; 
   PIII=exp(alpha3+beta3*averageMMP+gamma3*Age)/sum; 
   PC=1-PI-PII-PIII; 
run; 
ODS CSV file="D:\master report\master report\lung cancer\averageMMP and Age as predictor 
(multicategory response).csv";  
proc print data=probability (keep=averageMMP Age Staging PC PI PII PIII);  
run;  
ODS CSV close;  
run; 
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R code for section 5.5 
library(rpart) 
 
#read data 
MP=read.csv("D:master report\\MP1-revised.csv") 
L1=MP[21:44,] #These are the lung cancer and control data 
averageMMP1=1/3*(MP[21:44,5]+MP[21:44,6]+MP[21:44,7]) 
L2=cbind(L1, averageMMP1) 
attach(L2) 
 
#tree classification 
fit <- rpart(Staging ~ averageMMP1 + Age, 
    method="class", data=L2) 
printcp(fit) # display the results  
plotcp(fit) # visualize cross-validation results  
summary(fit) # detailed summary of splits 
 
# plot tree  
plot(fit, uniform=TRUE,  
    main="Classification Tree for lung cancer") 
text(fit, use.n=TRUE, all=TRUE, cex=.8) 
 
 
 
 
 
 
